Prof. Dr. Stipan Jonjić MD

Medicinski fakultet Katedra za histologiju i embriologiju

prostorija : Zavod za histologiju i embriologiju
mobitel : 091/1651206
e-pošta : stipan.jonjic@medri.uniri.hr

MEĐUNARODNA VIDLJIVOST:
CITATIH-INDEXI10-INDEX
Google Scholar 7588 45 106

Obrazovanje

1.1.1986. - Federal Research Center for Virus Diseases, Tübingen, Njemačka
1.1.1985. - doktorat znanosti Medicinski fakultet Rijeka
1.1.1982. - 1.1.1983. asistent Federal Research Center for Virus Diseases, Tübingen, Njemačka
1.1.1982. - magisterij znanosti Medicinski fakultet Rijeka
1.1.1971. - 1.1.1976. doktor medicine Medicinski fakultet Rijeka

Radno iskustvo

1.1.2006. - Voditelj Centra za proteomiku Medicinski fakulteta u Rijeci
1.1.1999. - 1.1.2003. Dekan Medicinski fakulteta Rijeka
1.1.1997. - 1.1.2007. Pročelnik Katedre za biologiju i medicinsku genetiku Medicinski fakultet Sveučilišta u Mostaru
1.1.1996. - Predstojnik Zavoda/Katedre za histologiju i embriologiju Medicinski fakultet Rijeka
1.1.1992. - Redoviti profesor Medicinski fakultet Rijeka
1.1.1990. - Izvanredni profesor Medicinski fakultet Rijeka
1.1.1986. - Docent Zavod za fiziologiju i imunologiju, Medicinski fakultet Rijeka
1.1.1982. - 1.1.1983. Asistent Federal Research Center for Virus Diseases, Tübingen, Njemačka
1.1.1979. - 1.1.1986. Asistent Zavod za fiziologiju i imunologiju, Medicinski fakultet Rijeka

Nagrade i priznanja

20.3.2017. Grad Rijeka - Nagrada za životno djelo
Državna nagrada "Ruđer Bošković" za značajna znanstvena otkrića u oblasti prirodnih znanosti u području biomedicine, posebno virusne imunologije za izučavanje uloge limfocita T u kontroli infekcije citomegalovirusom
Günther Weitzel Science Award 1994. (Liga za razvoj molekulske biologije i biotehnologije, Tübingen, Njemačka)
Orden predsjednika Republike Hrvatske - Red Danice Hrvatske s likom Ruđera Boškovića
Godišnja nagrada Županije primorsko - goranske za znanstveni rad
Prva nagrada Sveučilišta u Rijeci za najbolji znanstveni rad studenata
Nagrada grada Rijeke za međunarodno priznati znanstveni doprinos na području medicine a osobito u poznavanju uloge imunoloških mehanizama
Godišnja nagrada Hrvatske akademije znanosti i umjetnosti za doprinos od osobitog i trajnog značenja za Republiku Hrvatsku u području medicinskih znanosti
Priznanje Medicinskog fakulteta Sveučilišta u Rijeci za doprinos u razvoju stomatološke djelatnosti, nastave i znanosti
Raine Foundation Visiting Professor, University of Western Australia
Nagrada "Ante Šercer" Akademije medicinskih znanosti Hrvatske
Njemačka nacionalna akademija za znanost – Leopoldina
Državna nagrada za znanost Hrvatskog sabora - nagrada za životno djelo

Članstva

1.1.2017. - Hrvatsko društvo za proteomiku
1.1.2016. - 1.1.2020. Heinrich Pette Institute, Leibniz Institute for Experimental Virology (HPI), Scientific Advisory Board, član
1.1.2015. - European Academy of Microbiology
1.1.2014. - Član panela LS6 – 'Immunity and Infections' u Starting Grant 2014. evaluacijama
1.1.2013. - Predsjednik Savjeta za znanost Sveučilišta u Rijeci
1.1.2012. - Upravno vijeće Instituta za medicinska istraživanja i medicinu rada, Ministarstvo znanosti, obrazovanja i sporta
1.1.2010. - Upravni odbor Hrvatske zaklade za znanost
1.1.2006. - 1.1.2011. EU FP6/ FP7 Programme Committee – Zdravlje
1.1.2006. - 1.1.2010. Nacionalno povjerenstvo za FP7 projekte, predsjednik
1.1.2005. - Society for Natural Immunity
1.1.2002. - 1.1.2006. Hrvatsko imunološko društvo, predsjednik
1.1.2000. - 1.1.2003. Nacionalno vijeće za visoku naobrazbu
1.1.2000. - American Society for Microbiology
1.1.1994. - 1.1.2002. Nacionalno znanstveno vijeće

Nastavna djelatnost

Kolegiji

1.1.2005. - 1.1.2006. Imunost na viruse
Poslijediplomski doktorski studij Biomedicina
Medicinski fakultet Sveučilišta u Rijeci
voditelj
Norma sati:
1.1.2005. - 1.1.2006. Kultura stanica
Poslijediplomski doktorski studij Biomedicina
Medicinski fakultet Sveučilišta u Rijeci
voditelj
Norma sati:
1.1.2005. - Biologija herpes virusa
Poslijediplomski doktorski studij Biomedicina
Medicinski fakultet Sveučilišta u Rijeci
voditelj
Norma sati:
1.1.2005. - Imunologija razvojne dobi
Poslijediplomski stručni studij Pedijatrija
Medicinski fakultet Sveučilišta u Rijeci
voditelj
Norma sati:
1.1.1996. - 1.1.2001. Histologija s embriologijom
Integrirani preddiplomski i diplomski sveučilišni studij Dentalne Medicine
Medicinski fakultet Sveučilišta u Rijeci
voditelj
Norma sati:
1.1.1996. - Histologija i embriologija
Integrirani preddiplomski i diplomski sveučilišni studij Medicina
Medicinski fakultet Sveučilišta u Rijeci
voditelj
Norma sati:

Gostujući nastavnik

1.1.2007. - Kolegij virusne imunologije - Farmaceutsko-biokemijski fakultet Zagreb
Farmaceutsko-biokemijske znanosti
Farmaceutsko-biokemijski fakultet Zagreb
voditelj
Norma sati:
1.1.1997. - Biologija stanice i genetika - Medicinski fakultet Mostar

Medicinski fakultet Mostar
voditelj
Norma sati:
1.1.1995. - 1.1.2004. Imunost na viruse-Prirodno-matematički fakultet Zagreb
Biologija
Prirodno-matematički fakultet Zagreb
voditelj
Norma sati:

Izdavaštvo

- Histološki atlas

Financiranje: Medicinski fakultet Sveučilišta u Rijeci - Digital point

Znanstvena i umjetnička djelatnost

Znanstveni radovi

1. Molgora M, Bonavita E, Ponzetta A, Riva F, Barbagallo M, Jaillon S, Popovic B, Bernardini G, Magrini E, Gianni F, Zelenay S, Jonjic S, Santoni A, Garlanda C, Mantovani A
IL-1R8 is a checkpoint in NK cells regulating anti-tumor and anti-viral activity.
Nature - 2017.

Q1

2. Nabekura T, Gotthardt D, Niizuma K, Trsan T, Jenus T, Jonjic S, Lanier LL
Cutting Edge: NKG2D Signaling Enhances NK Cell Responses but Alone Is Insufficient To Drive Expansion during Mouse Cytomegalovirus Infection
Journal of Immunology 199 1567-1571 - 2017.

3. Cohrs RJ, Lee KS, Beach A, Sanford B, Baird NL, Como C, Graybill C, Jones D, Tekeste E, Ballard M, Chen X, Yalacki D, Frietze S, Jones K, Lenac Rovis T, Jonjić S, Haas J, Gilden D
Targeted Genome Sequencing Reveals Varicella-Zoster Virus Open Reading Frame 12 Deletion
Journal of Virology 7 - 2017.

4. Tršan T, Vuković K, Filipović P, Brizić AL, Lemmermann NAW, Schober K, Busch DH, Britt WJ, Messerle M, Krmpotić A, Jonjić S
Cytomegalovirus vector expressing RAE-1? induces enhanced anti-tumor capacity of murine CD8+ T cells
European Journal of Immunology 47 1354–1367 - 2017.

5. Zeeshan Chaudhry M, Kasmapour B, Plaza-Sirvent C, Bajagic M, Casalegno Garduno R, Borkner L, Lenac Rovis T, Scrima A, Jonjic S, Schmitz I, Cicin-Sain
UL36 Rescues Apoptosis Inhibition and In vivo Replication of a Chimeric MCMV Lacking the M36 Gene.
Frontiers in Cellular and Infection Microbiology 7 - 2017.

6. Hirche C, Frenz T, Haas SF, Döring M, Borst K, Tegtmeyer PK, Brizić Ilija, Jordan S, Keyser K, Chhatbar C, Pronk E, Lin S, Messerle M, Jonjić Stipan, Falk CS, Trumpp A, Essers MAG, Kalinke U
Systemic Virus Infections Differentially Modulate Cell Cycle State and Functionality of Long-Term Hematopoietic Stem Cells In Vivo.
Cell Reports 19 2345-2356 - 2017.

7. Miletic A, Lenartic M, Popovic B, Brizic I, Trsan T, Miklic K, Mandelboim O, Krmpotic A, Jonjic S
NCR1-deficiency diminishes the generation of protective murine cytomegalovirus antibodies by limiting follicular helper T-cell maturation.
European Journal of Immunology 1 - 2017.

8. Popović,Branka; Golemac, Mijo; Podlech, J; Železnjak, Jelena; Bilić-Zulle, Lidija; Lukić, Mijo; Čičin-Šain, Luka; Reddehase, M; Sparwasser, T; Krmpotić, Astrid; Jonjić, Stipan
IL-33/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infection.
Plos Pathogens 13 - 2017.

9. Chan B, Magalhaes VG, Lemmermann NAW, Juranić Lisnić V, Stempel M, Bussey KA, Reimer E, Podlech J, Lienenklaus S, Reddehase MJ, Jonjić S, Brinkmann MM
The murine cytomegalovirus M35 protein antagonizes type I IFN induction downstream of pattern recognition receptors by targeting NF-?B mediated transcription.
Plos Pathogenss 13 - 2017.

10. González-Motos V, Ritter B, Jürgens C, Kropp KA, Duran E, Larsen O, Ouwendijk WJD, Lenac Rovis T, Jonjic S, Verjans GMG, Sodeik B, Krey T, Bauerfeind R, Schulz TF, Kaufer BB, Kalinke U, Proudfoot AEI, Rosenkilde MM, Viejo-Borbolla A
Varicella zoster virus glycoprotein C increases chemokine-mediated leukocyte migration.
Plos Pathogens 15 - 2017.

11. Kavazović Inga, Lenartić Maja, Jelenčić Vedrana, Jurković Slaven, Lemmermann NA, Jonjić Stipan, Polić Bojan, Wensveen Felix
NKG2D stimulation of CD8+ T cells during priming promotes their capacity to produce cytokines in response to viral infection in mice.
European Journal of Immunnology Epub ahead of print - 2017.

Q1

12. Železnjak Jelena, Popović Branka, Krmpotić Astrod, Jonjić Stipan, Lisnić Juranić Vanda
Mouse cytomegalovirus encoded immunoevasins and evolution of Ly49 receptors - sidekicks or enemies?
Immunology Letters Epub ahead of print - 2017.

Q1

13. Aguilar O, Berry R, Rahim, M, Reichel J, Popović Branka, Tanaka M, Fu Z, Balaji G, Lau T, Tu M, Kirkham C, Mahmoud A, Mesci A, Krmpotić Astrid, Allan D, Makrigiannis A, Jonjić Stipan, Rossjohn J, Carlyle J
A Viral Immunoevasin Controls Innate Immunity by Targeting the Prototypical Natural Killer Cell Receptor Family
Cell 58 - 2017.

Q1
WOS

14. Diab M, Glasner A, Issacson B, Bar-On Y, Drori Y, Yamin R, Duev-Cohen A, Danziger O, Zamostiano R, Mandelboim M, Jonjic S, Bacharach E, Mandelboim O
NK-cell receptors NKp46 and NCR1 control human metapneumovirus infection.
European Journal of Immunnology 1 1-12 - 2017.

Q1
WOS

15. Seleme M, Kosmac K, Jonjic S, Britt W
TNF? Induced Recruitment of Inflammatory Mononuclear Cells Leads to Inflammation and Altered Brain Development in MCMV Infected Newborn Mice.
Journal of Virology 91 1-22 - 2017.

16. Milovanović J, Popović Branka, Milovanović M, Kveštak Daria, Arsenijević A, Stojanović B, Tanasković I, Krmpotić Astrid, Arsenijević N, Jonjić Stipan, Lukić M
Murine Cytomegalovirus Infection Induces Susceptibility to EAE in Resistant, BALB/C mice
Frontiers in Immunology 8 - 2017.

17. Sonntag E, Hamilton ST, Bahsi H, Wagner S, Jonjić S, Rawlinson WD, Marschall M, Milbradt J
Cytomegalovirus pUL50 is the multi-interacting determinant of the core nuclear egress complex (NEC) that recruits cellular accessory NEC components.
Journal of General Virology 97 1676-85 - 2016.

18. Thiel N, Keyser KA, Lemmermann N, Oduro JD, Wagner K, Elsner C, Halenius A, Lenac Rovis T, Brinkmann M, Jonjic S, Cicin-Sain L, Messerle M
The Mouse Cytomegalovirus Gene m42 Targets Surface Expression of the Protein Tyrosine Phosphatase CD45 in Infected Macrophages.
PLOS Pathogens 12 e1006057 - 2016.

19. Tomic A,Varanas PR, Golemac M, Malic S, Riese P, Borst EM, Mischak-Weissinger E, Guzmán CA, Krmpotić A, Jonjic S, Messerle M
Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand.
PLOS Pathogens 12 e1006015 - 2016.

20. Houston A, Williams J, Lenac Rovis T, Shanley D, O'Riordan R, Kiely P, Ball M, Barry O, Kelly J, Fanning A, MacSharry J, Mandelboim O, Singer B, Jonjic S, Moore T
Pregnancy-specific glycoprotein (PSG) expression in normal gastrointestinal tract and in tumours detected with novel monoclonal antibodies.
mAbs 8 491-500 - 2016.

Q1

21. Arapović M, Brizić I, Popović B, Jurković S, Jordan S, Krmpotić A, Arapović A, Jonjić S
Intrinsic contribution of perforin to NK cell homeostasis during viral infection.
Frontiers in Immunology 7 - 2016.

22. Borst EM, Bauerfeind R, Binz A, Stephan T, Neuber S, Wagner K, Steinbrück L, Sodeik B, Lenac Rovis T, Jonjic S, Messerle M
The Essential Human Cytomegalovirus Proteins pUL77 and pUL93 are Structural Components Necessary for Viral Genome Encapsidation.
Journal of Virology 90 5860-75 - 2016.

Q1

23. Vitenshtein A, Weisblum Y, Hauka S, Halenius A, Oiknine-Djian E,Tsukerman P, Bauman Y, Bar-On Y, Stern-Ginossar N, Enk J, Ortenberg R, Tai J, Markel G, Blumberg RS, Hengel H, Jonjic S, Wolf DG, Adler H, Kammerer R, Mandelboim O
CEACAM1-Mediated Inhibition of Virus Production
Cell Reports 15 2331–2339 - 2016.

24. Lenac Rovis Tihana, Kucan Brlic Paola, Kaynan N, Juranic Lisnic Vanda, Brizic Ilija, Jordan S, Tomic Adriana, Kvestak Daria, Babic Marina, Tsukerman P, Colonna M, Koszinowski U, Messerle M, Mandelboim O, Krmpotic Astrid, Jonjic Stipan
Inflammatory monocytes and NK cells play a crucial role in DNAM-1-dependent control of cytomegalovirus infection.
Journal of Experimental Medicine 213 1835-50 - 2016.

Q1

25. Lemmermann N, Krmpotic A, Podlech J, Brizic I, Prager A, Adler H, Karbach A, Wu Y, Jonjic S, Reddehase MJ, Adler
Non-redundant and redundant roles of cytomegalovirus gH/gL complexes in host organ entry and intra-tissue spread.
PLoS Pathogens DOI:10.1371/journal.ppat.1004640 - 2015.

Q1

26. Yossef R, Gur C, Shemesh A, Guttman O, Hadad U, Nedvetzki S, Miletic A, Nalbandyan K, Cerwenka A, Jonjic S, Mandelboim O, Porgador A
Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes.
PlosOne 10 2 - 2015.

Q1
WOS

27. Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N, Coppenhagen-Glazer S, Shussman N, Almogy G, Cuapio A, Hofer E, Mevorach D, Tabib A, Ortenberg R, Markel G, Miklic K, Jonjic S, Brennan CA, Garrett WS, Bachrach G, Mandelboim O
Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack.
Immunity 42 344-55 - 2015.

Q1
WOS

28. Stipan Jonjic
CMV Immunology.
Cellular and Molecular Immunology 12 125-7 - 2015.

Q1

29. Arapovic J, Arapovic M, Golemac M, Traven L, Tomac J, Rumora D, Razic E, Krmpotic A, Jonjic Stipan
The specific NK cell response in concert with perforin prevents CD8+ T cell-mediated immunopathology after mouse cytomegalovirus infection.
Medical Microbiology and Immunology, ahead of print 1 1 - 2015.

Q1

30. Bradford R, Yoo Y, Golemac M, Pugel E, Jonjic S, Britt WJ
Murine CMV-Induced Hearing Loss Is Associated with Inner Ear Inflammation and Loss of Spiral Ganglia Neurons.
PLoS Pathogens 11(4): e1004774. doi:10.1371/journal.ppat.1004774 11 - 2015.

31. Lisnic B, Juranic Lisnic V, Jonjic S
NK cell interplay with cytomegaloviruses
Current Opinion in Virology 15 18 - 2015.

Q1

32. Verweij M, Wellish M, Whitmer T, Malouli D, Lapel M, Jonjić S, Haas J, DeFilippis V, Mahalingam R, Früh K: Varicella Viruses Inhibit Interferon- Stimulated JAK-STAT Signaling through Multiple Mechanisms, PLoS Pathogens, 11(5): e1004901. doi:10.1371/journal.ppat., 2015
Varicella Viruses Inhibit Interferon- Stimulated JAK-STAT Signaling through Multiple Mechanisms.
Plos Pathogens 11 5 - 2015.

Q1

33. Glasner A, Šimić Hrvoje, Miklić Karmela, Roth Z, Berhani O, Khalaila I, Jonjić Stipan, Mandelboim O
Expression, Function, and Molecular Properties of the Killer Receptor Ncr1-Noé
Journal of Immunology 195 3959-3969 - 2015.

Q1

34. Brizić, Ilija; Lenac Roviš, Tihana; Krmpotić, Astrid; Jonjić Stipan
MCMV avoidance of recognition and control by NK cells
Seminars in immunology 36 641-50 - 2014.

35. Celis-Gutierrez, J; Boyron, M; Walzer, T; Pandolfi, PP; Jonjić, Stipan; Olive, D; Dalod, M; Vivier, E; Nunes, JA
Dok1 and Dok2 proteins regulate natural killer cell development and function
The EMBO Journal e201387404 - 2014.

36. Pyzik, M; Dumaine, AA; Charbonneau, B; Fodil-Cornu, N; Jonjić, S; Vidal, SM.
Viral MHC Class I-like Molecule Allows Evasion of NK Cell Effector Responses In Vivo
Journal of immunology pii: 1401386 - 2014.

Q1
WOS
Exc

37. Zarama, A; Perez-Carmona, N; Farre´, D; Tomić, Adriana; Borst, EM; Messerle, M; Jonjić, Stipan; Engel, P; Angulo, A.
Immunobiology of Congenital Cytomegalovirus Infection of the Central Nervous System - Murine Cytomegalovirus Model.
Plos pathogens (1553-7374) 10 - 2014.

Q1
WOS
Exc

38. Crouse, J; Bedeniković G; Wiesel, M; Ibberson, M; Xenarios, I; Von Laer, D; Kalinke, U; Vivier, E; Jonjić, Stipan; Oxenius, A
Type I Interferons Protect T Cells against NK Cell Attack Mediated by the Activating Receptor NCR1
Immunity (1074-7613) 40 (2014), 6; 961-73 40 961-73 - 2014.

Q1
WOS
Exc

39. Baird, NL; Bowlin, JL; Yu, X; Jonjić, Stipan; Haas, J; Cohrs, RJ; Gilden, D
Varicella zoster virus DNA does not accumulate in infected human neurons
Virology 1 458-459:1-3 - 2014.

Q1
WOS
Exc

40. Eifler, M; Uecker, R; Weisbach, H; Bogdanow, B; Richter, E; König, L; Vetter, B; Lenac-Roviš, Tihana; Jonjic, Sstipan; Neitzel, H; Hagemeier, C; Wiebusch, L
PUL21a-Cyclin A2 Interaction is Required to Protect Human Cytomegalovirus-Infected Cells from the Deleterious Consequences of Mitotic Entry
Plos pathogens 13 e1004514 - 2014.

Q1
WOS
Exc

41. Gabaev, I; Elbasani, E; Ameres, S; Steinbrück, L; Stanton, R; Döring, M; Lenac Roviš, Tihana; Kalinke, U; Jonjić, Stipan; Moosmann, A; Messerle, M.
Expression of the Human Cytomegalovirus UL11 Glycoprotein in Viral Infection and Evaluation of its Effect on Virus-Specific CD8 T Cells
Journal of virology 88 14326 - 2014.

Q1
WOS
Exc

42. Geyer, H; Hartung, E; Mages, HW; Weise, C; Beluzic, R; Vugrek, O; Jonjić, Stipan; Kroczek, RA; Voigt, S
Cytomegalovirus Expresses the Chemokine Homologue vXCL1 Capable of Attracting XCR1+ CD4- Dendritic Cells.
Journal of virology 88 292-302 - 2014.

Q1
WOS
Exc

43. Slavuljica, Irena; Kvestak, Daria; Huszthy, Peter; Kosmac, K; Britt, W; Jonjic, Stipan
Immunobiology of Congenital Cytomegalovirus Infection of the Central Nervous System - Murine Cytomegalovirus Model.
Cellular & molecular immunology epub - 2014.

44. Trilling, M; Khanh Le, V; Rashidi-Alavijeh, J; Katschinski, B; Scheller, J; Rose-John, S; Androsiac, G; Jonjić, Stipan; Poli, V; Pfeffer, K; Hengel H.
'Activated' S TAT proteins - a paradoxical consequence of inhibited JAK-STAT signalling in cytomegalovirus-infected cells.
Journal of immunology 192 447-58 - 2014.

Q1
WOS
Exc

45. Kosmac K, Bantug R, Pugel E, Cekinovic Dj, Jonjic S, Britt W
Glucocorticoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development
PLoS Pathogens 9 - 2013.

46. Handke W, Luig C, Popovic B, Krmpotic A, Jonjic S, Brune W
Viral inhibition of BAK promotes murine cytomegalovirus dissemination to salivary glands.
Journal of Virology 87 3592-6 - 2013.

47. Lankry D, Lenac Rovis T, Jonjic S, Mandelboim O
The interaction between CD300a and Phosphatidylserine inhibits tumor cell killing by NK cell.
European Journal of Immunology - 2013.

48. Wensveen FM, Klarenbeek PL, van Gisbergen K, Pascutti MF, Derks I, van Schaik B, ten Brinke A, de Vries N, Cekinovic D, Jonjic S, van Lier R, Eldering
Pro-Apoptotic Protein Noxa Regulates Memory T Cell Population Size and Protects against Lethal Immunopathology.
Journal of Immunology 190 1180-91 - 2013.

49. Borst M, Kleine-Albers J, Gabaev I, Babic M, Wagner K, Binz A, Degenhardt I, Kalesse M, Jonjic S, Bauerfeind R, Messerle M
The human cytomegalovirus UL51 protein is essential for viral genome cleavage-packaging and interacts with the terminase subunits pUL56 and pUL89.
Journal of Virology 87 1720-32 - 2013.

50. Yu X, Seitz S, Pointon T, Bowlin J, Cohrs R, Jonjić S, Haas J, Wellish M, Gilden D
Varicella Zoster Virus Infection of Highly Pure Terminally Differentiated Human Neurons.
Journal of Neurovirology 19 75-81 - 2013.

51. Geyer H, Hartung E, Mages HW, Weise C, Beluzic R, Vugrek O, Jonjic S, Kroczek RA, Voigt S
Cytomegalovirus expresses the chemokine homologue vXCL1 capable of attracting XCR1+CD4- dendritic cells
Journal of Virology 88 292-302 - 2013.

52. Trsan T, Busche A, Abram M, Wensveen FM, Lemmermann NA, Arapovic M, Babic M, Tomic A, Golemac M, Brinkmann MM, Jäger W, Oxenius A, Polic B, Krmpotic A, Messerle M, Jonjic S
Superior induction and maintenance of protective CD8 T cells in mice infected with MCMV vector expressing RAE-1?.
Proceedings of the National Academy of Sciences of the United States of America PNAS 110 16550-5 - 2013.

53. Trilling M, Khanh Le V, Rashidi-Alavijeh J, Katschinski B, Scheller J, Rose-John S, Androsiac G, Jonjic S, Poli V, Pfeffer K, Hengel H
'Activated' S TAT proteins - a paradoxical consequence of inhibited JAK-STAT signalling in cytomegalovirus-infected cells.
Journal of Immunology 192 447-58 - 2013.

54. Juranic Lisnic V, Babic Cac M, Lisnic B, Trsan T, Mefferd A, Mukhopadhyay CD, Cook CH, Jonjic S, Trgovcich J
Dual Analysis of the Murine Cytomegalovirus and Host Cell Transcriptomes Reveal New Aspects of the Virus-Host Cell Interface.
PLoS Pathogens in press - 2013.

55. Wensveen MF, Lenartic M, Jelencic V, Lemmermann AN, ten Brinke A, Jonjic S, Polic
NKG2D Induces Mcl-1 Expression and Mediates Survival of CD8 Memory T Cell Precursors via Phosphatidylinositol 3-Kinase.
Journal of Immunology 191 1307-15 - 2013.

Q1

56. Jordan S, Ruzsics Z, Mitrovic M, Baranek T, Arapovic J, Krmpotic A, Vivier E, Dalod M, Jonjic S, Döelken L, Koszinowski UH
Natural killer cells are required for extramedullary hematopoiesis following murine cytomegalovirus infection.
Cell Host & Microbe 535-545 - 2013.

57. Stanietsky N, Lenac T, Glasner A, Seidel E, Tsukerman P, Yamin R, Enk J, Jonjic S, Mandelboim O
Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR.
European Journal of Immunology - 2013.

58. Lenac Rovis T, Bailer SM, Pothineni VR, Ouwendijk WJ, Simic H, Babic M, Miklic K, Malic S, Verweij MC, Baiker A, Gonzalez O, von Brunn A, Zimmer R, Früh K,Verjans GM, Jonjic S, Haas J.
A comprehensive analysis of varicella zoster virus proteins using a new monoclonal antibody collection.
Journal of Virology 87 6943-6954 - 2013.

59. Miletić A, Krmpotić A, Jonjić S
The evolutionary arms race between NK cells and viruses: Who gets the short end of the stick?
European Journal of Immunology 43 867-77 - 2013.

60. Poglitsch, M, Weichhart T, Hecking M, Werzowa J, Katholnig K, AntlangerM, Krmpotic A, Jonjic S, Hörl W, Zlabinger G, PuchhammerE, Säemann M
CMV Late Phase-Induced mTOR Activation Is Essential for Efficient Virus Replication in Polarized Human Macrophages.
American Journal of Transplantation 2 1458-68 - 2012.

61. van Gisbergen K, Kragten N, Hertoghs K , WensveenF, JonjicS, Hamann J, Nolte M,van Lier R
Mouse Hobit is a homolog of the transcriptional repressor Blimp-1 that regulates NKT cell effector differentiation.
Nature Immunology 13 864-71 - 2012.

62. Glasner A, Zurunic A, Meningher T, Lenac Rovis T, Tsukerman P, Bar-On Y, Yamin R, Meyers A, Mandeboim M, Jonjic S, Mandelboim O
Elucidating the mechanisms of influenza virus recognition by Ncr1.
PLoS ONE 7 - 2012.

63. Mitrovic M, Arapovic J, Jordan S, Fodil-Cornu N, Ebert S, Vidal SM, Krmpotic A, Reddehase MJ, Jonjic S
The NK-cell response to mouse cytomegalovirus infection affects the level and kinetics of the early CD8+ T-cell response.; 2012
Journal of Virology 86 2165-75 - 2012.

64. Marcinowski L, Tanguy M, Krmpotic A, Rädle B, Juranic Lisnic V, Tuddenham L, Chane-Woon-Ming B, Ruzsics Z, Erhard F, Benkartek C, Babic M, Zimmer R, Trgovcich J, Koszinowski U, Jonjic S, Pfeffer S, Dölken L
Degradation of cellular miR-27 by a novel, highly abundant viral transcript is important for efficient virus replication in vivo.
PLOS Pathogens 8 2 - 2012.

65. Rodriguez-Martin S, Kropp K, Wilhelmi V, Juranic Lisnic V,Yuan Hsieh W, Blanc M, Livingston A, Busche A, Tekotte H, Messerle M, Auer M, Fraser I, Jonjic S, Angulo A, Reddehase M, Ghazal P
Ablation of the Regulatory IE1 Protein of Murine Cytomegalovirus Alters In Vivo Pro-inflammatory TNFalpha Production during Acute Infection.
PLoS Pathogens 8 - 2012.

66. Mandaric S, Walton S, Ruelicke T, Richter K, Girard-Madoux M, Clausen B, Zurunic A, Kamanaka M, Flavell R, Jonjic S, Oxenius A
IL-10 Suppression of NK/DC Crosstalk Leads to PoorPriming of MCMV-Specific CD4 T Cells and ProlongedMCMV Persistence.
PLoS Pathogens 8 - 2012.

67. Mitrovic M, Arapovic J, Traven L, Krmpotic A, Jonjić S
Innate immunity regulates adaptive immune response: lessons learned from studying the interplay between NK and CD8(+) T cells during MCMV infection.
Medical Microbiology and Immunology 201 487-95 - 2012.

68. Skenderi F, Jonjic S
Viral vaccines and vectors - some lessons from cytomegaloviruses.
Periodicum Biologorum 114 201-210 - 2012.

69. Slavuljica I, Krmpotić A, Jonjić S
Manipulation of NKG2D ligands by cytomegaloviruses: impact on innate and adaptive immune response.
Frontiers in Immunology 2 - 2011.

70. Kropp KA, Robertson KA, Sing G, Rodriguez-Martin S, Blanc M, Lacaze P, Noor Hassim MF, Khondoker MR, Busche A, Dickinson P, Forster T, Strobl B, Mueller M, Jonjic S, Angulo A, Ghazal P
Reversible inhibition of MCMV replication by IFN{gamma} in primary macrophages involves a primed type I IFN signaling sub-network for full establishment of an immediate-early antiviral-state.
Journal of Virology 85 10286-99 - 2011.

71. Jordan S, Krause J, Prager A, Mitrovic M,Jonjic S, Koszinowski UH, Adler B
Virus Progeny of MCMV Bacterial Artificial Chromosome pSM3fr Shows Reduced Growth in Salivary Glands Due to a Fixed Mutation of MCK-2.
Journal of Virology 85 10346-53 - 2011.

72. Babic M, Krmpotic A, Jonjic S
All is fair in virus-host interactions: NK cells and cytomegalovirus.
Trends in Molecular Medicine 17 1471-4941 - 2011.

73. Pyzik M, Charbonneau B, Gendron-Pontbriand EM, Babic M, Krmpotic A,Jonjic S,Vidal S
Distinct MHC class I-dependent NK cell-activating receptors control cytomegalovirus infection in different mouse strains.
Journal of Experimental Medicine 208 1105-17 - 2011.

74. Jonjic S, Trsan T
Resistance to Mousepox Virus: CD94 on a Special Mission.
Immunity 34 1458-68 - 2011.

75. Jovanovic I, Radosavljevic G, Mitrovic M, Lisnic Juranic V, McKenzie A, Arsenijevic N, Jonjic S, Lukic M S
ST2 Deletion Enhances Innate and Acquired Immunity to Murine Mammary Carcinoma. European
Journal of Immunology 41 1902-1912 - 2011.

76. Radosavljevic G, Jovanovic I, Majstorovic I, Mitrovic M, Lisnic VJ, Arsenijevic N,Jonjic S, Lukic ML
Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity.
Clinical and Experimental Metastasis 28 451-62 - 2011.

77. Colonna M, Jonjic S, Watzl C.
Natural Killer cells: fighting viruses and much more.
Nature Immunology 12 107–10 - 2011.

78. Babic M, Pyzik M, Zafirova B, Mitrovic M, Butorac V, Lanier LL, Krmpotic A, Vidal SM and Jonjić S:
Cytomegalovirus immunoevasin reveals the physiological role of „missing self" recognition in NK cell dependent virus control in vivo.
Journal of Experimental Medicine 207 2663-2673; - 2010.

79. Slavuljica I, Busche A, Babic M, Mitrovic M, Gasparović I, Cekinovic Dj, Markova Car E, Pernjak Pugel E, Cikovic A, Juranic Lisnic V, Britt WJ, Koszinowski U, Messerle M, Krmpotic A, Jonjic S
Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.
Journal of Clinical Investigation 120 4532-45 - 2010.

80. Lankry D, Simic H, Klieger Y, Levi-Schaffer F, Jonjic S, Mandelboim O:
Expression and function of CD300 in NK cells.
Journal of Immunology 185 2877-86 - 2010.

81. Doelken L, Krmpotic A, Koethe S, Tuddenham L, Tanguy M, Marcinowska L, Ruzsics Z, Elefant N, Altuvia Y, Margalit H, Koszinowski U, Jonjic S, Pfeffer S
Cytomegalovirus microRNAs facilitate persistant virus infection in salivary glands.
PloS Pathogens 14 10 - 2010.

82. Steer B, Adler B, Jonjic S, Stewart J, Adler H: A gammaherpesvirus complement regulatory protein promotes initiation of infection by activation of protein kinase Akt/PKB.
A gammaherpesvirus complement regulatory protein promotes initiation of infection by activation of protein kinase Akt/PKB.
PLoS ONE 21 7 - 2010.

83. Champsaur M, Beilke JN, Ogasawara K, Koszinowski UH, Jonjic S, Lanier LL
Intact NKG2D-Independent Function of NK Cells Chronically Stimulated with the NKG2D Ligand Rae-1.
Journal of Immunology 185 157-65 - 2010.

84. Juranic Lisnic V, Krmpotic A, Jonjic S
Modulation of natural killer cell activity by viruses. Current
Opinion in Microbiology 1-10 - 2010.

85. Jonjic S
Functional plasticity and robustness are essential characteristics of biological systems: lessons learned from KLRG1 deficient mice.
European Journal of Immunology 40 1241-3 - 2010.

86. Zhi L, Mans J, Paskow M, Brown P, Schuck P, Jonjić S, Natarajan K, and Margulies D
Direct interaction of the mouse cytomegalovirus m152/gp40 immunoevasin with RAE-1 isoforms
Biochemistry 49 2443-5 - 2010.

87. Zafirova B, Mandaric S, Antulov R, Krmpotic A, Jonsson H, Yokoyama WM, Jonjic S, Polic B
Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice.
Immunity 31 270-82 - 2009.

88. Dölken L, Jonjic S
Herpesviral MicroRNAs Close in on Their Prey.
Cell Host & Microbe 5 315-7 - 2009.

89. Arapovic J, Lenac T, Antulov R, Polic B, Ruzsics Z, Carayannopoulos LN, Koszinowski UH, Krmpotic A, Jonjic S.
Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus.
Journal of Virology 83 8198-207 - 2009.

90. Stanietsky N, Simic H, Arapovic J, Toporik A, Levy O, Novik A, Levine Z, Beiman M, Dassa L, Achdout H, Stern-Ginossar N, Tsukerman P, Jonjic S, Mandelboim O
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity.
Proceedings of the National Academy of Sciences of the United States of America 106 17858-63 - 2009.

91. Arapovic J, Lenac Rovic T, Reddy AB, Krmpotic A, Jonjic S
Promiscuity of MCMV immunoevasin of NKG2D: m138/fcr-1 down-modulates RAE-1epsilon in addition to MULT-1 and H60.
Molecular Immunology 47 114-2 2 - 2009.

92. Kielczewska A, Pyzik M, Sun T, Krmpotic A, Lodoen M B, Munks M W, Babic M, Hill A B, Koszinowski U H, Jonjić S, Lanier L, Vidal S
Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. Journal of Experimental Medicine 206(3):515-23
Journal of Experimental Medicine 206 515-23 - 2009.

93. Budt M, Niederstadt L, Valchanova RS, Jonjic S, Brune W
Specific inhibition of the PKR-mediated antiviral response by the murine cytomegalovirus proteins m142 and m143.
Journal of Virology 83 1260-70 - 2009.

94. Cicin-Sain L, Ruzsics Z, Podlech J, Bubic I, Menard C, Jonjic S, Reddehase M J, Koszinowski U H
Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an anti-apoptotic viral gene.
Journal of Virology 82 2056-64 - 2008.

95. Jonjic S, Polic B, Krmpotic A
Viral inhibitors of NKG2D ligands: Friends or foes of immune surveillance?
38 2952-6 - 2008.

96. Cekinovic D, Golemac M, Pugel EP, Tomac J, Cicin-Sain L, Slavuljica I, Bradford R, Misch S, Winkler TH, Mach M, Britt WJ, Jonjic S.
Passive immunization reduces MCMV induced brain pathology in newborn mice.
Journal of Virology 82 12172-80 - 2008.

97. Lenac T, Arapovic J, Traven L, Krmpotic A, Jonjic S: Murine cytomegalovirus regulation of NKG2D ligands. ;
Murine cytomegalovirus regulation of NKG2D ligands.
Medical Microbiology and Immunology 197 159-66 - 2008.

98. Jonjic S, Krmpotic A, Arapovic J, Koszinowski UH
Dissection of the antiviral NK cell response by MCMV mutants.
Methods in Molecular Biology 127-49 - 2008.

99. Bantug G, Cekinovic D, Bradford R, Koontz T, Jonjic S, Britt W J:CD8+ T-lymphocytes control MCMV replication in the central nervous system of newborn animals.
CD8+ T-lymphocytes control MCMV replication in the central nervous system of newborn animals.
Journal of Immunology 181 2111-23 - 2008.

100. Jonjic S, Babic M, Polic B, Krmpotic A
Immune evasion of natural killer cells by viruses.
Current Opinion in Immunology 20 30-8 - 2008.

101. Koontz T, Bralic M, Tomac J, Pernjak-Pugel E, Bantug G, Jonjic S, Britt W J
Altered Development of the Brain after Focal Herpesvirus Infection of the CNS.
Journal of Experimental Medicine 205 423-35 - 2008.

102. Cicin-Sain L, Bubic I, Schnee M, Ruzsics Z, Mohr C, Jonjic S, Koszinowski U H
Targeted deletion of regions rich in immune evasive genes from the cytomegalovirus genome as novel vaccine strategy.
Journal of Virology 81 13825-34 - 2007.

103. Mans J, Natarajan K, Balbo A, Schuck P, Eikel D, Hess S, Robinson H, Simic H, Jonjic S, Tiemessen C T, Margulies D H
Cellular Expression and Crystal Structure of the Murine Cytomegalovirus MHC-Iv Glycoprotein, m153.
Journal of Biological Chemistry 282 35247-58 - 2007.

104. Klenovsek K, Weisel F, Schneider A, Appelt U, Jonjić S, Messerle M, Bradel-Tretheway B, Winkler TH, Mach M
Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells.
Blood 110 3472-9 - 2007.

105. Lenac T, Budt M, Arapovic J, Hasan M, Zimmermann A, Simic H, Krmpotic A,Messerle M, Ruzsics Z, Koszinowski U H,Hengel H, Jonjic S
The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60.
Journal of Experimental Medicine 203 1843-50 - 2006.

106. Girard Adam S, Caraux A, Fodil-Cornu N, Concepcion Loredo-Osti J, Lesjean-Pottier S, Jaubert J, Bubic I, Jonjic S, Guénet J, Vidal S, Colucci F.
Cmv4, a new locus linked to the natural killer cell gene complex, controls innate resistance to cytomegalovirus in wild-derived mice.
Journal of Immunology 176 5478-85 - 2006.

107. Buch T, Polic B, Clausen B E, Weiss S, Akilli-Ozturk O, Chang C-H, Flavell R, Schulz A, Jonjic S, Waisman A, Förster I
MHC class II expression through a hitherto unknown pathway supports T helper cell dependent immune responses: implications for MHC class II deficiency.
Blood 107 1434-44 - 2006.

108. Zimmermann A, Trilling M, Wagner M, Wilborn M, Bubic I, Jonjic S, Koszinowski UH, Hengel H
A cytomegaloviral protein reveals a dual role for STAT2 in IFN-? signaling and antiviral responses.
Journal of Experimental Medicine 201 1543-53 - 2005.

109. Krmpotic A, Hasan M, Loewendorf A, Saulig T, Halenius A, Lenac T, Polic B, Bubic I, Kriegeskorte A, Pernjak Pugel E, Messerle M, Hengel H, Busch D, Koszinowski UH, Jonjic S
NK cell activation through the NKG2D ligand Mult-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145.
Journal of Experimental Medicine 201 211-220 - 2005.

110. Hasan M, Krmpotic A, Ruzsics Z, Bubic I, Lenac T, Halenius A, Loewendorf A, Messerle M, Hengel H, Jonjic S, Koszinowski UH
Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J
Journal of Virology 79 2920-2930 - 2005.

111. Strobl B, Bubic I, Bruns U, Steinborn R, Laiko R, Kolbe T, Karaghiosoff M, Kalinke U, Jonjic S, Müller M
Novel functions of Tyk2 in the antiviral defense against murine cytomegalovirus. Journal of Immunology 175(6):4000-4008; 2005
Journal of Immunology 175 4000-4008 - 2005.

112. French A.R, Pingel J.T, Wagner M, Bubic I, Yang L, Kim S, Koszinowski, Jonjic S, Yokoyama W.M
Escape of mutant double-straned DNA virus from innate immune control.
Immunity 747-756 - 2004.

113. Bubic I, Wagner M, Krmpotic A, Saulig T, Kim S, Yokoyama WM, Jonjic S, Koszinowski UK
Gain-of-Virulence Caused by Loss of a Gene in Murine Cytomegalovirus.
Journal of Virology 7536-7544 - 2004.

114. Jonjic S, Traven L:
Small countries receive even less of a fair deal. Nature ; 2004
Nature 429 601-601 - 2004.

115. Cicin-Sain L, Brune W, Bubic I, Jonjic S, Koszinowski UH
Vaccination of mice with bacteria carrying a cloned herpesvirus genome reconstituted in vivo.
Journal of Virology 8249-8255 - 2003.

116. Hasan M, Polic B, Bralic M, Jonjic S, Rajewsky K
Incomplete block of B cell development and immunoglobulin production in mice carrying the &mgr; MT mutation on the BALB/c background.
European Journal of Immunology 3463-3471 - 2002.

117. Krmpotic A, Busch D, Bubic I, Gebhardt F, Hengel H, Hasan M, Scalzo A, Koszinowski U.H, Jonjić S
MCMV glycoprotein gp40 confers virus resistance to CD8+T cells and NK cells in vivo.
Nature Immunology 529-35 - 2002.

118. Brune W, Hasan M, Krych M, Bubic I, Jonjic S, Koszinowski UH
Secreted Virus – Encoded Proteins Reflect Murine Cytomegalovirus productivity in Organs.
Journal of Infectious Diseases 184 - 2001.

119. Wagner M, Michel D, Schaarschmidt P, Vaida B, Jonjic S, Messerle M, Mertens T, Koszinowski U H
Comparison between Human Cytomegalovirus pUL97 and Murine Cytomegalovirus (MCMV) pM97 Expressed by MCMV and Vaccinia Virus: pM97 Does Not Confer Ganciclovir Sensitivity.
Journal of Virology 10729-10736 - 2000.

120. Trgovcich J, Stimac D, Polic B, Krmpotic A, Pernjak-Pugel E, Tomac J, Hasan M, Wreber B, Jonjic S
Immune responses and cytokine induction in the development of severe hepatitis during acute infections with murine cytomegalovirus.
Archives of Virology 1-18 - 2000.

121. Wagner M, Jonjic S, Koszinowski UH, Messerle M
Systematic Excision of Vector Sequences from the BAC-Cloned Herpesvirus Genome during Virus Reconstitution
Journal of Virology 7056-7060 - 1999.

122. Markotic A, Lümen R, Marusic A, Jonjic S, Müthing J
Ganglioside expression in tissues of mice lacking the tumor necrosis factor receptor 1.
Carbohydrate Research 75-87 - 1999.

123. Krmpotic A, Messerle M, Crnkovic-Mertens I, Polic B, Jonjic S, Koszinowski UH
The Immunoevasive Function Encoded by the Mouse Cytomegalovirus Gene m152 protects the Virus against T Cell Control in Vivo.
Journal of Experimental Medicine 1285-1295 - 1999.

124. Hengel H, Reusch U, Gutermann A, Ziegler H, Jonjic S, Lucin P, Koszinowski UH
Cytomegaloviral control of MHC class I function in the mouse.
Immunological Reviews 167-176 - 1999.

125. Knezevic N, Nikolic B, Brajsa K, Spaventi R, Jonjic N, Jonjic S, Marusic S
Monoclonal Antibodies Against Maternal Major Histocompatibility Complex Class I Molecules Induce Rapid Abortion in Mice.
Journal of Reproductive Immunology 217-223 - 1999.

126. Jonjic S, Mutter W, Weiland F, Reddehase MJ, Koszinowski UH
Site restricted persistent cytomegalovirus infection after selective long term depletion of CD4 positive T lymphocytes.
Journal of Experimental Medicine 1199-1212 - 1999.

127. Kucic N, Jonjic S, Koszinowski UH, Lucin P
Characterization of murine cytomegalovirus 34 kDa glycoprotein that forms a complex with the cell surface MHC class I molecules.
Periodicum Bilogorum 100 469-476 - 1998.

128. Trgovcich J, Pernjak-Pugel E, Tomac J, Koszinowski UH, Jonjic S
Pathogenesis of Murine Cytomegalovirus Infection in Neonatal Mice.
Monographs in Virology 42-53 - 1998.

129. Polic B, Hengel H, Krmpotic A, Trgovcich J, Pavic I, Lucin P, Jonjic S, Koszinowski UH
Hierarchical and Redundant Lymphocyte Subset Control Precludes Cytomegalovirus Replication during Latent Infection.
Journal of Experimental Medicine 1047-1054 - 1998.

130. Crnkovic-Mertens I, Messerle M, Milotic I, Szepan U, Kucic N, Krmpotic A, Jonjic S, Koszinowski UH
Virus Attenuation after Deletion of the Cytomegalovirus Fc Receptor Gene Is Not due to Antibody Control.
Journal of Virology 1377-1382 - 1998.

131. Koszinowski UH, Volkmer HJ, Messerle M, Jonjic S, Wittek R
Cytotoxic T lymphocytes induced by vaccinia recombinant expressing a herpesvirus nonstructural immediate early protein protect against cytomegalovirus infection.
Vaccines 41-45; - 1998.

132. Rukavina T, Ticac B, Susa M, Jendrike N, Jonjic S, Lucin P, Marre R, Doric M, Trautmann M
Protective Effect of Antilipopolysaccharide Monoclonal Antibody in Experimental Klebsiella Infection.
Infection and Immunity 1754-1760 - 1997.

133. Jonjic S, Lucin P
The Science at Croatian Universities: A Gloomy View through SCIsearch and MEDLINE
Croatian Medical Journal 2-6 - 1996.

134. Polic B, Jonjic S, Pavic I, Crnkovic I, Zorica I, Hengel H, Lucin P, Koszinowski UH
Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo.
Journal of General Virology 217 -225 - 1996.

135. Lucin P, Jonjic S
How to organize postgraduate study? A model.
Periodicum Biologorum 4 - 1995.

136. Lucin P, Jonjic S
Cytomegalovirus replication cycle: an overview.
Periodicum Biologorum 97:1 - 1995.

137. Marusic A, Katavic V, Stimac D, Kusec V, Jonjic S
Bone turnover in homozygous b2-microglobuline knock-out mice does not differ from that in their heterozygous littermates.
Journalof Clinical Chemistry and Clinical Biochemistry 915-918 - 1995.

138. Polic B, Jonjic S, Pavic I, Crnkovic I, Dujmovic M, Zorica I, Hengel H, Kucic N, Lucin P, Koszinowski UH.
Control of cytomegalovirus infection in MHC class I deficient mice.
Scandinavian Journalof Infectious Diseases Suppl. 52-53 - 1995.

139. Lucin P, Jonjic S, Hengel H, Pavic I, Polic B, Crnkovic I, Thäle R, Zorica I, Koszinowski U H
Cytomegalovirus persistence in salivary glands by evasion from immunological control.
Regional Immunology 391-397 - 1995.

140. Jonjic S, Pavic I, Polic B, Crnkovic I, Lucin P, Koszinowski UH
Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus.
Journal of Experimental Medicine 1713-1717 - 1994.

141. Reddehase MJ, Balthesen M, Rapp M, Jonjic S, Pavic I, Koszinowski UH
The Conditions of Primary Infection Define the Load of Latent Viral Genome in Organs and the Risk of Recurrent Cytomegalovirus Disease.
Journal of Experimental Medicine 185-193 - 1994.

142. Koszinowski UH, Jonjic S, Lucin P
Cytomegalovirus persistence by evasion from immune control.
Seminars in Virology 297-305 - 1994.

143. Hengel H, Lucin P, Jonjic S, Ruppert T, Koszinowski UH
Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape.
Journal of Virology 289-297 - 1994.

144. Lucin P, Jonjic S, Messerle M, Polic B, Hengel H, Koszinowski UH
Late phase inhibition of murine cytomegalovirus replication by synergic action of interferon gamma and tumor necrosis factor.
Journal of General Virology 101-110 - 1994.

145. Polic B, Pavic I, Crnkovic I, Lucin P, Trobonjaca Z, Jonjic S
The role of CD4+ and CD8+ T lymphocytes in viral immunity.
Croatian Medical Journal 294-300 - 1993.

146. Pavic I, Polic B, Crnkovic I, Lucin P, Jonjic S, Koszinowski UH
Participation of endogenous tumour necrosis factor alpha in host resistance to cytomegalovirus infection.
Journal of General Virology 2215-2223 - 1993.

147. Lucin P, Polic B, Crnkovic I, Lucin K, Rukavina D, Jonjic S
Involvement of CD4+ T lymphocytes and macrophages in the low dose streptozotocin induced diabetes in CBA mice.
Croatian Medical Journal 9–16 - 1992.

148. Lucin P, Pavic I, Polic B, Jonjic S, Koszinowski UH
Gamma interferon dependent clearance of cytomegalovirus infection in salivary glands.
Journal of Virology 1977 – 1984 - 1992.

149. Koszinowski UH, Reddehase MJ, Jonjic S
The role of CD4 and CD8 T cells in viral infections
Current Opinion in Immunology 471 – 475 - 1991.

150. Jonjic S, Pavic I, Lucin P, Grkovic I, Rukavina D
The role of T lymphocyte subsets in the control of cytomegalovirus infection.
Periodicum Biologorum 23-24 - 1990.

151. Lucin P, Rukavina D, Crnkovic I, Tomac J, Jonjic S
Effect of L3T4 and/or Lyt 2 T cell depletion on low dose streptozotocin induced diabetes in mice.
Periodicum Biologorum 95-95 - 1990.

152. Jonjic S, Pavic I, Lucin P, Rukavina D, Koszinowski UH
Efficacious control of cytomegalovirus infection after long term depletion of CD8+ T lymphocytes.
Journal of Virology 5457 5464 - 1990.

153. Jonjic S, Karboun A T, Susa M, Lucin P, Haller H, Jonjićc N, Rukavina D
The role of CD4+ and CD8+ T cell subsets in the rejection of the tumor allograft.
Iugoslavica physiologica et pharmacologica acta 157-158 - 1989.

154. Del Val M, Volmer MJ, Rothbard JB, Jonjic S, Messerle M, Schickedanz J, Reddehase MJ, Koszinowski UH
Molecular basis for cytolytic T lymphocyte recognition of the murine cytomegalovirus immediate early protein pp89.
Journal of Virology 3965-3972 - 1988.

155. Jonjic S, del Val M, Keil GM, Reddehase MJ, Koszinowski UH
A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection.
Journal of Virology 1653-1658 - 1988.

156. Reddehase MJ, Jonjic S, Weiland F, Mutter W, Koszinowski UH
Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4 helper independent antiviral function of CD8 positive memory T lymphocyte derived from latently infected donors.
Journal of Virology 1061-1065 - 1988.

157. Nick S, Metzger B, Jonjic S, Falke D
Suppression of humoral antibody formation against sheep red blood cells by infections with HSV 2 and influence of mouse cytomegalovirus.
Archives of Virology 131-135 - 1987.

158. Koszinowski UH, Reddehase MJ, Keil GM, Volkmer HJ, Jonjic S, Messerle M, del Val M, Mutter W, MGnch K, Buhler B
Molecular analysis of herpesviral gene products recognized by protective cytolytic T lymphocytes.
Immunology Letters 185-192 - 1987.

159. Volkmer HJ, Bertholet C, Jonjic S, Wittek R, Koszinowski UH
Cytolytic T lymphocyte recognition of the murine cytomegalovirus nonstructural immediate early protein pp89 expressed by recombinant vaccinia virus.
Journal of Experimental Medicine 668-677 - 1987.

160. Saalmuller A, Reddehase M, Bühring HJ, Jonjić S, Koszinowski UH
Simultaneous expression of CD4 and CD8 antigens by substantial proportion of resting porcine T lymphocytes.
European Journal of Immunology 1297-1301 - 1987.

161. Jonjic S, Radosevic Stasic B, Cuk M, Jonjic N, Rukavina D
Class II antigens induction in the regenerating liver of rats after partial hepatectomy.
Transplantation 49- 54 - 1987.

162. Jonjic N, Jonjic S, Saalmuller A, Rukavina D, Koszinowski UH
Distribution of T lymphocyte subsets in porcine lymphoid tissues.
Immunology 395-401 - 1987.

163. Saalmuller A, Jonjić S, Buhring HJ, Reddehase MJ, Koszinowski UH
Monoclonal antibodies reactive with swine lymphocytes. II. Detection of an antigen on resting T cells down regulated after activation.
Journal of Immunology 1852-1857 - 1987.

164. Zec J, Orlic P, Matic Glazar D, Dimec D, Velcic G, Zelic M, Uravic M, Vukas D, Cohar F, Vujaklija Stipanovic K, Miculinic Ivancic E, Crnic Martinovic M, Jonjic S, Rukavina D, Sepic A
14 years of kidney transplantation in Rijeka.
Periodicum Biologorum 90-91 - 1986.

165. Jonjic S, Vujaklija Stipanovic K, Fucak M, Cuk M, Kapovic M, Crnic M, Matic Glazar D, Rukavina D
Immune competence in long term renal allograft recipients.
Periodicum Biologorum 76-77 - 1986.

166. Manestar D, Matutinovic T, Jonjic S, Rukavina D, Gjuraj C
Immune competence of tonsillar lymphocytes in children undergoing tonsillectomy.
Periodicum Biologorum 254-255 - 1986.

167. Jonjic S, Rukavina D
Maternal and offspring alloimmunisation during pregnancy in sheep.
Periodicum Biologorum 355-360 - 1986.

168. Vujaklija Stipanovic K, Doric M, Crnic Martinovic M, Fucak M, Jonjic S, Cuk M, Polic L, Sepic A, Rukavina D
Spontaneous development of donor specific tolerance in renal allograft recipients.
Periodicum Biologorum 575-576 - 1986.

169. Jonjic S, Pavlica N, Doric M, Rukavina D
Investigation of the immunoregulatory potential of fetal and neonatal spleen and liver cells in rats.
Periodicum Biologorum 319-324 - 1986.

170. Orlic P, Jonjic S, Matic Glazar D, Grzetic M, Zec J, Rukavina D
Immune competence in patients under immunosuppressive therapy with CsA.
Periodicum Biologorum 567-568 - 1986.

171. Jonjic S, Jonjic N, Rukavina D
Perspektiva imunosupresivne terapije monoklonskim protutijelima koja prepoznaju diferencijacijske antigene na T limfocitima.
Acta Facultatis Medicae Fluminensis 11 102-107 - 1986.

172. Doric M, Rukavina D, Jonjic S
Immune responsiveness in offsprings of adoptively immunized mothers.
Immunobiology 92-98 - 1986.

173. Reddehase MJ, Weiland F, MGnch K, Jonjic S, LGske A, Koszinowski UH
Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs.
Journal of Virology 264-273 - 1985.

174. Doric M, Rukavina D, Jonjic S
Increase in the number of plaque forming cells in the spleen of newborns from adoptively immunied mothers.
Folia Biologica 141-144 - 1984.

175. Doric M, Rukavina D, Jonjic S
Increase in the number of plaque forming cells in the spleen of newborns from adoptively immunied mothers.
Folia Biologica 141-144 - 1984.

176. Jonjić S, Koszinowski UH
Monoclonal antibodies reactive with swine lymphocytes. I. Antibodies to membrane structures that define the cytolytic T lymphocyte subset in the swine.
Journal of Immunology 647-652 - 1984.

177. Kapovic M, Rukavina D, Jonjic S, Nemarnik J
Effect of multiparity on immune response in rat.
Periodicum Biologorum 85 89-90 - 1983.

178. Radosevic Stasic B, Jonjic S, Polic L, Rukavina D
Immune response of rats after pharmacological pinealectomy.
Periodicum Biologorum 119-121 - 1983.

179. Doric M, Jonjic S, Rukavina D
Immunological activity of lymphoid organs in pregnant rats.
Periodicum Biologorum 87-88 - 1983.

180. Jonjic S, Doric M, Rukavina D
Regulation of the immunological response to mitogens and allogeneic cells by fetal liver and spleen cells.
Periodicum Biologorum 21-22 - 1983.

181. Doric M, Rukavina D, Jonjic S
Immune response in offsprings of adoptively immunized mothers.
Iugoslavica physiologica et pharmacologica acta 27-28 - 1983.

182. Jonjic S, Rukavina D
Immunoregulation with foetal and neonatal liver and spleen cells.
Iugoslavica physiologica et pharmacologica acta 69-73 - 1983.

183. Rukavina D, Jonjić S
The effects of the transplacental traffic of lymphocytes..
Periodicum Bilogorum 65-66 - 1976.

184. Krmpotic A, Bubic I, Polic B, Lucin P, Jonjic S
Pathogenesis of murine cytomegalovirus infection.
Microbes and Infection 1263-1277

Znanstvene knjige

1. Prijevod poglavlja
Stipan Jonjić
Imunost na mikroorganizme, poglavlje 16, str. 339-357;
Stanična i molekularna imunologija, 8. izdanje, ISBN: 978-953-176-819-1 Drago Batinić, Vesna Lukinović-Škudar Medicinska naklada Zagreb Zagreb - 2018.
2. Prijevod poglavlja
Stipan Jonjić
Imunost na tumore, poglavlje 18, str. 383-397
Stanična i molekularna imunologija, 8. izdanje, ISBN: 978-953-176-819-1 Drago Batinić, Vesna Lukinović-Škudar, Medicinska naklada Zagreb Zagreb - 2018.
3. Autor poglavlja u knjizi
Cekinović Đ, Juranić Lisnić V, Jonjić S
Rodent models of congenital cytomegalovirus infection.
Human Cytomegaloviruses, Methods and Protocols, Methods in Molecular Biology, Andrew Yurochko Humana Press Springer New York, USA - 2014.
4. Autor poglavlja u knjizi
Matthias J. Reddehase
Murine Model of Neonatal Cytomegalovirus Infection Chapter II.6, Cytomegaloviruses From Molecular Pathogenesis to Intervention
Cytomegaloviruses From Molecular Pathogenesis to Intervention Matthias J. Reddehase Caister Academic Press Njemačka - 2013.
5. Autor poglavlja u knjizi
Matthias J. Reddehase
Innate Immunity to Cytomegalovirus in the Murine Model. Chapter II.9, Cytomegaloviruses From Molecular Pathogenesis to Intervention
Cytomegaloviruses From Molecular Pathogenesis to Intervention Matthias J. Reddehase Caister Academic Press Njemačka - 2013.
6. Autor poglavlja u knjizi
J. Zimmer
Virus Interactions with NK Cell Receptors: Natural Killer Cells.
Springer-Verlag J. Zimmer Springer-Verlag Njemačka - 2009.
7. Autor poglavlja u knjizi
Vassil St. Georgiev, Karl A. Western, JJ McGowan
Innate Immunity to Mouse Cytomegalovirus in National Institute of Allergy and Infectious Diseases, NIH: Frontiers in Research
National Institute of Allergy and Infectious Diseases, NIH: Frontiers in Research, assil St. Georgiev, Karl A. Western, JJ McGowan, The Humana Press SAD - 2008.
8. Autor poglavlja u knjizi
J. Ewbank, E. Vivier
Dissection of the Antiviral NK Cell Response by MCMV Mutants n: editors: pp. 127-149, , 2008
Methods in Molecular Biology, vol. 415: Innate Immunity J. Ewbank, E. Vivier The Humana Press Inc. - 2008.
9.
Peter Lachmann
Microbial Subversion of NK Cell Function
Microbial Subversion of Immunity: Current Topics Peter Lachmann Caister Academic Press Njemačka - 2006.
10. Autor poglavlja u knjizi
Matthias J. Reddehase
Innate Immunity to Cytomegalovirus
Cytomegaloviruses: Molecular Biology and Immunology, Matthias J. Reddehase Caister Academic Press Njemačka - 2005.
11. Autor poglavlja u knjizi
J. Coligan, A. Kruisbeek, D. Marguiles, E. Shevach & W. Strober
Current Protocols in Immunology
J. Coligan, A. Kruisbeek, D. Marguiles, E. Shevach & W. Strober John Wiley SAD - 2001.
12. Autor poglavlja u knjizi
Thomas B B, Marcel Dekker
The Role of T lymphocyte subsets in the control of cytomegalovirus infection.
Viruses and the Cellular Immune Response.Inc Thomas B B, Marcel Dekker SAD - 1991.
13. Autor poglavlja u knjizi
Proc.of the 7th Int. Con. Immunol
Molecular analysis of the protective immune response to murine cytomegalovirus
Progress in Immunology Proc.of the 7th Int. Con. Immunol Springer-Verlag Berlin - 1989.
14. Autor poglavlja u knjizi
Bulg. Acad. Sci. Press
Interaction of fetuses and "placebo" fetus on systemic immune response.
Immunology of Reproduction , Proc. of the Fifth Int. Symp. Bulg. Acad. Sci. Press Bulg. Acad. Sci. Press Bugarska - 1982.
15. Autor poglavlja u knjizi
Proc. of the Fifth Int. Symp.
Regulatory cells in fetal spleen and liver in rats and mice.
Immunology of Reproduction ( Proc. of the Fifth Int. Symp. Bulg. Acad. Sci. Press Bugarska - 1982.
16.
Immunology of Reproduction
Materno fetal relationship and transplantation reactivity in the perinatal period of sheep
Proc. of the Fourth Int. Symp. Proc. of the Fourth Int. Symp. Bulg. Acad. Sci. Press, Bugarska - 1979.

Pozvana predavanja

1. 1. međunarodni studentski kongres s biomedicinskom tematikom,
Viral immuno-subversive mechanisms: can we make them work for us?
Rijeka, Hrvatska - 2.11.2017.
2. International Retreat for PhD students in Immunology
''Cytomegalovirus regulation of innate immune response.'',
Verona, Italija - 6.10.2017.
3. 42nd International Herpesvirus Workshop (IHW2017
''NK cells mediate microglia polarization during congenital CMV infection''
Ghent, Belgija - 29.7.2017.
4. Medical University of Vienna, Immunology research cluster
''Cytomegalovirus expressing NKG2D ligand Rae-1 gamma as a tumor vaccine vector''
Beč, Austrija - 18.5.2017.
5.
''Cytomegalovirus evasion of DNAM-1 dependent immune control by inflammatory monocytes and NK cells''
Godišnji sastanak Hrvatskog imunološkog društvaOgulin, Hrvatska - 14.10.2016.
6.
''Congenital cytomegalovirus infection and neuroinflammation'', HAZU symposium: Translation of Basic Immunology and Neuroscience Tools to Therapies: Where are we now?
Rijeka, Hrvatske - 4.7.2016.
7.
''Analiza transkriptoma kao moćan alat za istraživanje virusnih strategija izbjegavanja imunološkog odgovora''
HAZU simpozij:Primijenjena genomika u Republici Hrvatskoj, Zagreb, Hrvatska - 17.5.2016.
8.
''Regulation of CD8 T cell response to viral infection - lessons from cytomegalovirus immunoevasins''.
Ludwig-Maximilian-University, SFB seminar,Institute for Immunology, Munich, Germany - 23.10.2015.
9.
"Vaccines and innate immunity: lessons from cytomegalovirus immunoevasion"
Belgrade, Serbia: 3rd Belgrade EFIS symposium on immunoregulation, immunity, infection, autoimmunity and aging - 25.5.2015.
10. Stipan Jonjić, Tihana Lenac Roviš, Paola Kučan, Ilija Brizic, Noa Stanietsky, Vanda Juranić Lisnić, Stefan Jordan, Adriana Tomić, Marina Babić, Pinchas Tsukerman, Martin Messerle, Ofer Mandelboim, Astrid Krmpotić
''Cytomegalovirus downregulation of PVR reveals strong effect of DNAM-1 in virus control by NK cells and macrophages''
NK2015. Fairmont le Chateau Montebello, Quebec, Canada - 6.5.2015.
11.
''Pathogenesis of cytomegalovirus infection in ovary: Mechanisms of differential resistance of corpora lutea and follicles to infection''
Brisbane, Australia, 5th International Congenital CMV Conference and 15th International CMV/Betaherpesvirus Workshop - 24.4.2015.
12.
''From basic discoveries to academic entrepreneurship in adverse economic conditions''
Miltenyi Biotec GmbH, Bergisch Gladbach, Koeln, Germany - 4.3.2015.
13. Konferencija: uloga znanosti u razvoju društva i ekonomije
''From basic discoveries in immunology to academic entrepreneurship:The role of science in the development of economy and society''.
Ured za transfer tehnologije Sveučilišta u Splitu - 28.1.2015.
14.
"NKG2D independent immune function of RAE-1: enhanced CD8 T cell response induced by CMV vector expressing RAE-1 gamma"
Deutsches Rheuma Forschungszentrum , Berlin, Germany - 17.1.2015.
15.
''Innate & Adaptive Immunity Interface''
Waldthausen Castle, Budenheim, Germany, 2nd Waldthausen Cytomegalovirus Symposium, University of Mainz - 21.11.2014.
16.
''Genetically modified and immunologically attenuated herpesviruses as potent vaccine vectors.''
Primošten. Power of Viral Vectors in Gene Therapy and Basic Science Summer School, Hrvatsko mikrobiološko društvo, French Society of Cell and Gene Therapy, German Society for Gene Therapy, te  Spanish Society for Gene and Cell Therapy - 21.9.2014.
17.
''Differential innate immune resistance of ovarian corpora lutea and follicles to cytomegalovirus infection''
Krk: Godišnja skupština Hrvatskog imunološkog društva, HID 2014<br> - 18.9.2014.
18.
''CMV vaccine research – coupling the innate and adaptive immunity arms''
Bertinoro, Italija;University of Bologna: 2nd European Seminar in Virology - 13.6.2014.
19.
''Lecture on ERC grant, ERC Advanced Grant''
Ljubljana. Slovenija: National Institute of Chemistry - 25.4.2014.
20.
Upgrading the research capacity of the University of Rijeka, Faculty of Medicine through REGPOT
Warsaw University of Life Sciences, Warsaw, Poland - 27.3.2014.
21.
''Academic entrepreneurship: views from biomedicine''
Zagreb:Economic Institute - 11.3.2014.
22.
''Enhancing the CD8 T cell response by RAE-1 gamma expressed in a herpesvirus vector – not only NKG2D" Immunology Seminar, Cambridge Institute for Medical&nbsp; Research
Cambridge, Velika Britanija - 14.2.2014.
23.
''Recognition of murine cytomegalovirus infected cells by activating an inhibitory Ly49 NKcell receptors" Virus &Immunity course
Lyon, Francuska - 13.2.2014.
24.
''Expression of NKG2D ligand improves vaccine properties of recombinant cytomegalovirus'' PhD seminar on Institute of Immunology, Department of Pathobiology, University of Veterinary Medicine
Vienna, Austria - 28.11.2013.
25.
''Expression of NKG2D ligand RAE-1 gamma by recombinant cytomegalovirus enhances its immunogeneicity and vaccine efficacy'' PhD course on tumor immunology and immunotherapy, Center for Immunity and Infection Lausanne, Ludwig institute for cancer research
Lausanne, Switzerland - 5.11.2013.
26.
''Curious case of specific recognition of MCMV by NK cells: the role of uORFs and ncRNAs.'' NK2013 - 14th Meeting of the Society for Natural Immunity
Heidelberg, Germany - 19.9.2013.
27.
''Viral regulation of inhibitory and activating Ly49 receptors'' 15th International Congress of Immunology ICI2013
Milano, Italia - 23.8.2013.
28.
''NKG2D -dependent and -independent immune function of RAE-1: superior induction and maintenance of protective CD8 T cells in mice infected with MCMV vector expressing RAE-1'' Medical Immunology Campus
Erlangen, Njemačka - 1.7.2013.
29.
''MCMV transcript with multiple coding and non-coding functions needed for recognition of infected cells by activating Ly49 NK cell receptors'' 4th CMI Symposium on Immunology: Innate Immunity and NK Cells
4th CMI Symposium on Immunology: Innate Immunity and NK Cells, Hefei, Anhui Province, China - 17.6.2013.
30.
''Expression of NKG2D ligand by cytomegalovirus enhances virus immunogenicity and vaccine efficacy'' Introductory lecture at the Meeting of class II, German National Academy for Science Leopoldina
Introductory lecture at the Meeting of class II, German National Academy for Science Leopoldina, Halle, Germany - 23.5.2013.
31.
"Recognition of murine cytomegalovirus infected cells by activating an inhibitory Ly49 NK cell receptors" International Graduate School in Molecular Medicine
International Graduate School in Molecular Medicine Ulm, Germany - 11.4.2013.
32.
''Differential requirements for activating and inhibitory Ly49 receptors in recognition of MCMV-infected cells" ETH Zürich (Eidgenössische Technische Hochschule Zürich)
Zürich, Switzerland - 28.2.2013.
33.
''Strengthening adaptive immunity via innate immunity." Doctoral School of Biomedicine–Department of Molecular Medicine University of Padova
Padova, Italy - 20.2.2013.
34.
"NK cells in MCMV infection – from no function to too many functions" CMV LiaisonSymposium, Max von Pettenfoker-Institut,
CMV LiaisonSymposium, Max von Pettenfoker-Institut, Minhen, Njemačka - 16.11.2012.
35.
Highly attenuated Herpes virus vector expressing NKG2D ligand RAE-1g provides longlivedmemory CD8+ T cells with outstanding protective capacity " TWINCORE-Symposium
TWINCORE-Symposium, Hannover, Germany - 28.9.2012.
36.
"Activating and inhibitory LY49 receptors havedifferential requirements for recognition of MCMV- infected cells" European Congress of Immunology
European Congress of Immunology, Glasgow, Scotland - 5.9.2012.
37.
"Highly attenuated herpesvirus vector expressing NKG2D ligand RAE-1 provides long-livedmemory CD8 T cells with outstanding protective capacity." Microbiological-Infectological Seminar, Virological Institute
Microbiological-Infectological Seminar, Virological Institute, Ulm, Germany - 4.6.2012.
38.
"Enhancing the adaptive immune response by the NKG2D ligandexpressed in a herpesvirusvector" 13th meeting of the Society for Natural Immunity
13th meeting of the Society for Natural Immunity, Asilomar, California, USA - 21.4.2012.
39.
"Can we improveCD8 response to viral infection - lessons fromcytomegalovirus expressingNKG2D ligand." Washington University, School of Medicine
WashingtonUniversity, School of Medicine, St.Louis, USA - 18.4.2012.
40.
"Vaccines and innate immunity: lessons from cytomegalovirus imunoevasion of NKG2D" Final Symposium of the SFB 490"Invasion and Persistence of Infectious Organisms"
Final Symposium of the SFB 490"Invasion and Persistence of Infectious Organisms", Mainz, Germany - 8.3.2012.
41.
"Vaccines and innate immunity: lessons from cytomegalovirus immunoevasion of NKG2D." British Society of Immunology congress
British Society of Immunology congress, Liverpool, UK - 5.12.2011.
42.
"Viral interference with activating and inhibitory NK cell receptors." 3rd South East European Immunology School (SEEIS2011)
3rd South East European Immunology School (SEEIS2011), Arandjelovac, Serbia - 1.10.2011.
43.
"How can viruses teach us to make better vaccines and vaccine vectors?" 7th ISABS Conference in Forensic, Anthropological and Medical Genetics and Mayo Clinic Lectures in Translational Medicine
7th ISABS Conference in Forensic, Anthropological and Medical Genetics and Mayo Clinic Lectures in Translational Medicine, Bol, Brač - 21.6.2011.
44.
"MCMV interference with activating and inhibitory Ly49 NK cell receptors." SFB900 seminar, Hannover Medical School
SFB900 seminar, Hannover Medical School, Germany - 16.6.2011.
45.
"Recent advances in the pathogenesis of CMV infection." 21st ECCMID/27th ICC
Milano, Italy - 7.5.2011.
46.
''Expression of NKG2D ligand improves vaccine properties of recombinant cytomegalovirus" Natural Killer Cell Symposium
Mainz, Germany - 20.4.2011.
47.
"Vaccine properties of recombinant herpesvirus expressing ligand for NKG2D receptor", Annual Meeting of the Austrian Society for Allergology and Immunology
Beč, Austria - 3.12.2010.
48.
"Pathogenesis of CMV infection of the fetal brain, 3rd Congenital Cytomegalovirus Conference
Paris, France - 24.9.2010.
49.
"Cytomegalovirus protein m04 abolishes NK cell activation via the "missing-self" recognitionmechanism"14th International Congress of Immunology (ICI 2010) , "Viral infection"Symposia
Kobe, Japan - 23.8.2010.
50.
"Activation and inhibition of NK cells by murine cytomegalovirus - dual function of viral m04 protein"Karolinska Instituet
Stockholm, Sweden - 8.10.2009.
51.
Uvodno predavanje i predsjedavanje Workshop-u Microbial Evasion of the Immune System, 2nd European Congress of Immunology
Berlin,Germany - 13.9.2009.
52.
"Viral inhibitors of NKG2D ligands", Symposium 'The MIC Genes and Antibodies - From Bench to Bedside', 2nd European Congress of Immunology
Berlin,Germany - 13.9.2009.
53.
"Immmunobiology of recombinant MCMV expressing ligandfor NKG2D receptor", Workshop 'Receptors and regulation'; 7th Consortial Meeting EC6 Marie Curie Project 'NK Defense and therapy'
Düsseldorf, Germany - 10.9.2009.
54.
''Modes of regulation of NK cells by cytomegalovirus", 5th Annual Meeting of the Ph.D. Graduate Course GRK1045
Velen,Germany - 25.8.2009.
55.
"Inhibition and activation of NK cells by murine cytomegalovirus", Macroregional Network for Cell Therapy in Hematopoietic Stem Cell Transplant Recipients,(u organizaciji University of Padova Medical School)
Bressanone, Italija - 27.4.2009.
56.
"Pathogenesis of congenital virus infection of the central nervous system", SISSA ( Scuola Internazionale Superiore di Studi Avanzati)
Trst, Italija - 9.3.2009.
57.
"The role of MCMV protein m04 in the regulation of NK cells", 6th Consortial Meeting EC6 Marie Curie Project"NK Defense and Therapy"
Beč, Austrija - 24.2.2009.
58.
"Activation and inhibition of NK cells by MCMV -the role of m04 protein", Max von Pettenkofer-Institute, Ludwig Maximilians University
München, Njemačka - 19.12.2008.
59.
"Regulation ofNK cell response by catomegalovirus -implications on viral pathogenesis", Institut de Bacteriologie, Faculty of Medicine, University Louis Pasteur
Strasbourg, Francuska - 28.11.2008.
60.
"The MCMV m04 protein plays a role in both the inhibition and activation of NK cells"11th Meeting of the Society for Natural Immunity:NK2008
Fremantle, Western Australia, Perth, Australija - 27.10.2008.
61.
"Activation and inhibition ofNK cells by murine cytomegalovirus",Microbiology Seminar, Raine Medical Research Foundation, University of Western Australia
Perth, Australija - 24.10.2008.
62.
"Pathogenesis of congenital cytomegalovirus infection of the central nervous system; insights from and animal model",Raine Lecture, Raine Medical Research Foundation, University of Western Australia
Perth, Australija - 22.10.2008.
63.
"Activation and inhibition of NK cells by murine cytomegalovirus", Second EFIS / EJI Belgrade Symposium (Inflamation at the Interface of Innate and Acquired Immunity)
Beograd, Srbija - 7.9.2008.
64.
"Pathogenesis of congenital CMV infection: animal model", 20th Annual Meeting of the EACD (European Academy of Childhood Disability)
Zagreb, Hrvatska - 5.6.2008.
65.
"Activation and inhibition of NK cell responses by murine cytomegalovirus", EFIS – EJI Natural Killer Cell Symposium
Bad Herrenalb, Njemačka - 22.5.2008.
66.
"Viral evasion of NK cell response", ETH Institute of Microbiology
Zurich, Švicarska - 1.4.2008.
67.
"NK cell immune evasion by murine cytomegalovirus", Keystone Symposia
Keystone, Colorado, SAD - 25.2.2008.
68.
"Downregulation of NKG2D ligands by CMV", Annual Meeting of the French Society for Immunology: Immunity Infection and Vaccination, 26. – 29. studenoga 2007, Lyon, Francuska
Lyon, Francuska - 27.11.2007.
69.
"Altered development and immune response of the brain following cytomegalovirus infection innewborne mice"
Marseille, Francuska - 23.11.2007.
70.
"Viral regulation of innate immunity", Waldthausen Castle Symposium Cytomegalovirus
Mainz, Njemačka - 19.10.2007.
71.
"U.S. – Croatian scientific collaboration: the importance of the joint NIH funding", Conference: Increasing U.S. – Croatian Cooperation in the ICT, Biotechnology and Pharmaceutical Industry
Split, Hrvatska - 1.10.2007.
72.
"Regulation of NK cell responses by murine cytomegaloviruses",
Vienna, Austria - 29.6.2007.
73.
"Regulation of NK cell responses by murine cytomegaloviruses", 5th NationalConference SIICA Italian Society of Immunology, clinical immunology and allergology
Trst, Italija - 6.6.2007.
74.
''Viral immune evasion of NKG2D", 94th Annual Meeting of the AAI: Immunology
Miami,Florida, SAD - 19.5.2007.
75.
"Regulation of NK cell response by MCMV", 11th International CMV & Betaherpes virus workshop
Toulouse, Francuska - 13.5.2007.
76.
"Differential regulation of NKG2D ligands by MCMV", Croatian – Israeli Kick-off Meeting on Viral Immunology and Pathogenesis
Rijeka, Hrvatska - 23.3.2007.
77.
"Regulation of NK cell responses by murine cytomegalovirus",Institut für Virologie
Düsseldorf, Njemačka - 5.2.2007.
78.
"Different modes of NK cell regulation by MCMV", Seminar SFB 455, Gene Center,
München, Njemačka - 13.12.2006.
79.
"Murine CMV infection models and potential therapies", 2nd Consortium meeting EC project "NK defense and therapy"
Beč, Austrija - 17.11.2006.
80.
"Down-regulation ofNKG2D ligands by CMV", 6th Louis Pasteur Conference on Infectious Diseases "Shaping and Subversion of the immune system by Microbes", The Institute Pasteur,
Paris, Francuska - 15.11.2006.
81.
"Activation and inhibition ofNK cells by murine cytomegalovirus"1st Mini-Herpesvirus Workshop
Berlin, Njemačka - 29.9.2006.
82.
"Subversion of NK cell activation by murine cytomegalovirus", Department of Molecular and Cellular Biology, Centro Nacional de Biotecnologia (CSIC)
Madrid, Španjolska - 5.7.2006.
83.
"Murine cytomegalovirus inhibits NK cell activation by down-modulation of cellular ligands for NKG2D receptor", 2nd FEMS Congress of European Microbiologists
Madrid, Španjolska - 4.7.2006.
84.
"Murine CMV as a model for human CMV infection: principles of immunosurveillance and viralimmunoevasion",NIAID RESEARCH CONFERENCE
Opatija, Hrvatska - 25.6.2006.
85.
"Innate immunity to cytomegalovirus and viral evasion of NK cell response",Virus and Immunity
Lyon, Francuska - 6.2.2006.
86.
"Evasion of NK cell control by murine cytomegalovirus", the Institute for Microbiology and Hygiene, University of Freiburg
Freiburg, Njemačka - 23.1.2006.
87.
''Evasion of NK cell control by murine cytomegalovirus'' Institut für Klinische und Molekulare Virologie Nationales Referenzzentrum für Retroviren Friedrich-Alexander-Universität Erlangen-Nürnberg
Erlangen, Njemačka - 20.1.2006.
88.
"Molecular and cellular approaches to microbial pathogenesis"Summer school, The Graduate College "Mucosal Host-Pathogen-Interactions" of the School of Veterinary Medicine Hannover and the Medical School Hannover
Freiburg, Njemačka - 4.10.2005.
89.
"MCMV proteins which interfere with the expression of NKG2D ligands"International Titisee Conferences – Cell biology meets the immune system: molecular aspects of host pathogen interactions
Schwarzwald,Njemačka - 6.4.2005.
90.
"Multiple strategies to evade NKG2D by MCMV", Keystone Symposia – Innate Immunity to Pathogens,
Keystone, Colorado, SAD - 8.1.2005.
91.
"Interplay of MCMV with NK cell response", Max von Pettenkofer Institut
Minhen, Njemačka - 9.12.2004.
92.
"Immune evasion of viruses and tumors by downregulation of cellular ligands forNKG2D receptor", 2nd Slovenian Immunology Congress with International Participation
Portorož, Slovenija - 21.10.2004.
93.
15. - 17. 01.2015."Murine cytomegalovirus subvert NK cell control by interfering with expression of NKG2Dligands", Institute Pasteur
Paris, Francuska - 25.6.2004.
94.
''Regulation of NK cell response by BY murine cytomegalovirus", Rudolf Virchow Center for Experimental Biomedicine, University of Würzburg
Würzburg, Njemačka - 26.2.2004.
95.
"Modulation of NK cell response by murine cytomegalovirus", Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda
Madrid, Španjolska - 22.1.2004.
96.
"Deletion of MCMV m157 gene reveals the function of NKG2D silencing viral genes also in CMV1 positive mice", Stimulatory and Inhibitory Receptors of the Innate Immune System, Instituto Juan March de Estudios e Investigaciones
Madrid, Španjolska - 19.1.2004.
97.
"Murine cytomegalovirus-mediated regulation of NK cell response", University of Alabama,
Birmingham, Alabama, SAD - 1.8.2003.
98.
"Regulation of NK cell function by MCMV", Department of Pathology, College of Medicine and Public health, The Ohio State University
Columbus, Ohio, SAD - 25.6.2003.
99.
"Regulation of NK cell activity by murine cytomegalovirus", Veterinary University of Vienna
Beč, Austrija - 25.10.2002.
100.
"The MCMV m152/GP40 glycoprotein downregulates expressionof a cellular ligand for the NKG2D receptor and inhibits NK cell-mediated virus control in vivo", Molecular Mechanisms of Immune Modulation: lessons from Viruses
Madrid, Španjolska - 26.2.2002.
101.
"In vivo significance of MCMV evasion genes for MHC I", Department of Pathology, College of Medicine and Public health, The Ohio State University
Columbus, Ohio, SAD - 5.6.2001.
102.
"In vivo significance of MCMV evasion genes (M152, M06 AND M04) in regulation of CD8+ T cell response", Department of Microbiology & Immunology, Fairchild Science Building, Stanford University School of Medicine
Stanford, CA, SAD - 9.5.2001.
103.
"Immune evasion of T cell and NK response by cytomegalovirus proteins, 1st Slovenian Immunology Meeting - Immunology and Clinic III, Immunity in Infection
Portorož, Slovenija - 27.10.2000.
104.
"Immunobiology and pathogenesis of murine cytomegalovirus deletion mutants", Department of Immunology, The Scrips Research Institute
La Jolla,California, SAD - 31.3.1998.
105.
"In vivo significance of murine cytomegalovirus immunoevasion genes", Department of Microbiology & Immunology, Fairchild Science Building, Stanford University School of Medicine
Stanford, California, SAD - 23.3.1998.
106.
"MCMV:true molecular latency or low-level persistence? The role ofT cell subsets and cytokines", Human Cytomegalovirus Latency and Reactivation, Weston La Paloma
Tuscon, SAD - 20.3.1998.
107.
"Immunopathology and theTNF-alph involvement in MCMV infection in newborn mice", 1st International Consensus Round Table Meeting on CMV-Related Immunopathology
Stanford, California, SAD - 8.8.1997.
108.
"Characterization of immune mechanisms controlling recurrent cytomegalovirus infection", The Third International Meeting "Mechanisms in Local Immunity"
Stanford, California, SAD - 26.9.1996.
109.
"Plasticity of immune response", The Annual Meeting - League for the development of molecular biology and biotechnology (MoBBEL)
Tübingen, Njemačka - 6.10.1995.
110.
"Control of recurrent CMV by T cells, NK cells and cytokines", Virologisches Seminar, Institut for Medical Virology, University of Heidelberg
Heidelberg, Njemačka - 31.8.1995.
111.
"Antiviral antibodies are not essential for resolution of primary cytomegalovirus infection", Hadassah Medical Organization, Liver unit, University of Jerusalem
Izrael - 27.9.1994.
112.
"Adoptive transfer of immunity against cytomegalic virus infection and implication for other infections", European Association for Study of the Liver (EASL) Meeting, Atena Symposia: "Potentials of adoptive immunotherapy in the treatment of viral and neoplastic diseases of the liver"
Atena, Greece - 6.9.1994.
113.
"The componenets of the immune response in control of viral infections", Annual Meeting of Israeli Microbiological Society, Department of Microbiology and Immunology, Faculty of Health Science, Ben-Gurion University
Beer-Sheva, Izrael - 1.4.1994.
114. Masterclass VacTrain
''CMV-based anticancer vaccines''
Leiden, Nizozemska
115.
"Regulation of inhibitory and activating Ly49 receptors by murine cytomegalovirus." Virus & Immunity course
Virus &Immunity course, Lyon, France
116.
"Highly attenuated MCMV vector expressing NKG2D ligand RAE-1 gamma provides long- lived memory CD8+T cells with outstanding protective capacity." 14th InternationalCMV/BetaHerpesvirus workshop
San Francisco, USA
117. Društvo imunologa Srbije
''Viral regulation of PVR (CD155) reveals a robust capacity of DNAM-1 in cytomegalovirus control by mononuclear phagocytes and NK cells''
Beograd, Srbija
118.
"Cytomegalovirus immunoevasin reveals the physiological role of "missing self" recognitioninNK cell dependent virus control in vivo", 35th Annual International HerpesvirusWorkshop
Salt Lake City, Utah, USA
119. ECCI - European Congenital Cytomegalovirus Initiative 2016
''Dynamics of CMV specific CD8 response in brain of mice infected as newborns''
San Servolo, Venecija, Italija
120. Immunology and Cancer Research Special Seminar, The Lautenberg Center for General The Faculty of Medicine and Tumor Immunology, The Hebrew University of Jerusalem-Hadassah Medical School, The Lautenberg Center for General The Faculty of Medicine and Tumor Immunology, The Hebrew University of Jerusalem-Hadassah Medical School
''Can viruses teach us to make better vaccine vectors – lessons from viral immunoevasion of innate immune receptors''
Jeruzalem, Izrael
121.
''Scientific career in adverse economic and social conditions''
Barcelona, Španjolska: 24th European Society of Clinical Microbiology and Infectious Diseases ECCMID2014

Kongresna priopćenja

1.
Lenac Rovis T, Stanietsky N, Juranic Lisnic V, Jordan S, Tomic A, Babic M, Tsukerman P, Mandelboim O, Krmpotic A, Jonjic S
Deletion of CMV inhibitor of PVR (CD155) results in enhanced virus susceptibility to innate immune control and dramatic attenuation in vivo poster, oralna prezentacij 39th Annual International Herpesvirus Workshop (IHW2014) Kobe, Japan - 18.7.2014.
2.
Trsan T, Abram M, Lemmermann N, Del Val M, Krmpotic A, Messerle M, Jonjic S
NKG2D ligand RAE-1? expressed by CMV vector promotes antigen presentation to CD8 T cells. poster, oralna prezentacija 39th Annual International Herpesvirus Workshop (IHW2014) Kobe, Japan - 18.7.2014.
3.
Brizic I, Wagner B, Prager A, Trsan T, Arapovic M, Lemmermann N, Podlech J, Reddehase M, Lemnitzer F, Bosse J, Gimpfl M, Marcinowski L, MacDonald M, Adler H, Koszinowski U, Adler B.
The Viral Chemokine MCK-2 of Murine Cytomegalovirus Promotes Infection as Part of a gH/gL/MCK-2 Complex. poster 2nd Meeting of Middle-European Societies for Immunology and Allergology Opatija, Hrvatska - 10.10.2013.
4.
Trsan T, Busche A, Abram M, Wensveen F, Lemmermann N, Arapovic M, Babic M, Tomic A, Golemac M, Brinkmann M, Jäger W, Oxenius A, Polic B, Krmpotic A, Messerle M, Jonjic S
RAE-1? ligand expression by MCMV vector promotes induction and maintenance of protective immune memory. poster 2nd Meeting of Middle-European Societies for Immunology and Allergology Opatija, Croatia - 10.10.2013.
5.
Juranic Lisnic V, Babic Cac M, Popovic B, L'Hernault A, Lisnic B, Krmpotic A, Doelken L, Jonjic S
Complex recognition of MCMV infected cells by activating Ly49 receptor. poster 2nd Meeting of Middle-European Societies for Immunology and Allergology Opatija, Croatia - 10.10.2013.
6.
Lenac Rovis T, Stanietsky N, Jordan S, Juranic Lisnic V, Tomic A, Babic M, Krmpotic A, Tsukerman P, Mandelboim O, Jonjic S
CMV regulation of mouse PVR. 2nd Meeting of Middle-European Societies for Immunology and Allergology Opatija, Croatia - 10.10.2013.
7.
Trsan T, Busche A, Abram M, Wensveen F, Lemmermann N, Arapovic M, Babic M, Tomic A, Golemac M, Brinkmann M, Jäger W, Oxenius A, Polic B, Krmpotic A, Messerle M, Jonjic
RAE-1? ligand expression by MCMV vector promotes induction and maintenance of protective immune memory poster NK2013 - 14th Meeting of the Society for Natural Immunity Heidelberg, Germany - 19.9.2013.
8.
Rovis T, Stanietsky N, Jordan S, Juranic Lisnic V, Tomic A, Babic M, Krmpotic A, Tsukerman P, Mandelboim O, Jonjic S
Complex viral regulation of PVR by MCMV to avoid NK cell recognition. poster NK2013 - 14th Meeting of the Society for Natural Heidelberg, Germany - 19.9.2013.
9.
Popovic B, Milovanovic M, Krmpotic A, Lukic M, Jonjic S
Deletion of IL-33 receptor reduces NK cell and CD8 T cell responses to herpesvirus infection. poster 15th International Congress of Immunology ICI2013 Milano, Italia - 23.8.2013.
10.
Lenac Rovis T, Stanietsky N, Jordan S, Juranic Lisnic V, Tomic A, Babic M, Krmpotic A, Tsukerman P, Mandelboim O, Jonjic S
CMV regulation of mouse PVR. poster 15th International Congress of Immunology ICI2013 Milano, Italia - 23.8.2013.
11.
Babic Cac M, Juranic Lisnic V, Pyzik M, Popovic B, Vidal SM, Krmpotic A, Jonjic S
Differential requirements of activating and inhibitory Ly49 receptors in recognition of MCMV-infected cells. poster 15th International Congress of Immunology ICI2013 Milano, Italia - 23.8.2013.
12.
Tršan, Tihana; Busche, Andreas; Abram, Maja; Babić Čač, Marina; Golemac, Mijo; Tomić, Adriana; Krmpotić, Astrid; Messerle, Martin; Jonjić, Stipan;
RAE-1? expressed by recombinant herpesvirus dramatically improves its vector capacity and promotes specific immune response - 1.1.2012.
13.
Lisnić, Vanda Juranić; Čač, Marina Babić; Lisnić, Berislav; L’Hernault, Anne; Doelken, Lars; Krmpotić, Astrid; Trgovcich, Joanne; Jonjić, Stipan;
MCMV transcriptome analysis and identification of a new, highly abundant transcript with multiple coding and non-coding functions - 1.1.2012.
14.
Tršan, Tihana; Busche, Andreas; Babić, Marina; Tomić, Adriana; Golemac, Mijo; Lemmermann, Niels; Brinkmann, Melanie; Jäger, Wiebke; Abram, Maja; Krmpotić, Astrid;
Highly attenuated MCMV vector expressing NKG2D ligand RAE-1 gamma provides long-lived memory CD8+ T cells with outstanding protective capacity - 1.1.2012.
15.
Lisnić, Vanda Juranić; Čač, Marina Babić; Lisnić, Berislav; Jonjić, Stipan; Trgovcich, Joanne;
Towards a better understanding of virus–host interplay: transcriptomic analysis of MCMV infection - 1.1.2012.
16.
Jonjić, Stipan;
ACTIVATING AND INHIBITORY LY49 RECEPTORS HAVE DIFFERENTIAL REQUIREMENTS FOR RECOGNITION OF MCMV-INFECTED CELLS - 1.1.2012.
17.
Tršan, Tihana; Busche, Andreas; Abram, Maja; Babić Čač, Marina; Tomić, Adriana; Brinkmann, Melanie; Krmpotić, Astrid; Messerle, Martin; Jonjić, Stipan;
Expression of NKG2D ligand by cytomegalovirus enhances its vaccine vector capacity - 1.1.2012.
18.
Tršan, Tihana; Slavuljica, Irena; Busche, Andreas; Babić Čač, Marina; Golemac, Mijo; Mihelčić, Mirna; Abram, Maja; Krmpotić, Astrid; Messerle, Martin; Jonjić, Stipan;
Improved sensitization of CD8+ T cell response after infection with MCMV expressing NKG2D ligand - 1.1.2011.
19.
Babić Čač, M; Pyzik, M; Zafirova, B; Mitrović, M; Krmpotić, A; Vidal, S; Jonjić, S;
Mouse cytomegalovirus restores' self'to prevent'missing self' - 1.1.2011.
20.
Lisnić, Vanda Juranić; Čač, Marina Babić; Cook, Charles; Jonjić, Stipan; Trgovcich, Joanne;
Transcriptomic profile of murine cytomegalovirus in vitro and in vivo - 1.1.2011.
21.
Lisnić, Vanda Juranić; Čač, Marina Babić; Jonjić, Stipan; Trgovcich, Joanne;
Transcriptomic profile of murine cytomegalovirus - 1.1.2011.
22.
Wensveen, Felix M; Jelencić, Vedrana; Gulin, Maja; Šimić, Hrvoje; Jonjić, Stipan; Polić, Bojan;
KAC: A novel biological system for the rapid production of site-specific biotinylated monoclonal antibodies - 1.1.2011.
23.
Golemac, Mijo; Cekinović, Đurđica; Bradford, Russell; Pugel, Ester Pernjak; Britt, William J; Jonjić, Stipan;
Long Term Sensorineural Hearing Loss in MCMV-infected Newborn Mice - 1.1.2011.
24.
Jonjić, Stipan;
CYTOMEGALOVIRUS PROTEIN M04 ABOLISHES NK CELL ACTIVATION VIA THE''MISSING-SELF''RECOGNITION MECHANISM - 1.1.2010.
25.
Mitrović, Maja; Arapović, Jurica; Simić, Hrvoje; Boneta, Jelena; Tomac, Jelena; Krmpotić, Astrid; Jonjić, Stipan;
THE ROLE OF PERFORIN IN NK CELL AND CD8 T CELL MEDIATED CONTROL OF MOUSE CYTOMEGALOVIRUS INFECTION - 1.1.2010.
26.
Cekinović, Đurđica; Pernjak Pugel, Ester; Ciković, Ana; Golemac, Mijo; Bradford, Russel; Britt, William J; Jonjić, Stipan;
Role of virus specific antibodies in the control of MCMV infection in newborn mice - 1.1.2010.
27.
Babić, Marina; Pyzik, Michal; Kielczewska, Agnieszka; Krmpotić, Astrid; Vidal, Silvia M; Jonjić, Stipan;
THE MOUSE CYTOMEGALOVIRUS PROTEIN PREVENTS NK CELL ACTIVATION VIA „MISSING SELF “MECHANISM - 1.1.2010.
28.
Vojvoda, Valerija; Bendelja, Krešo; Turkalj, Mirjana; Aberle, Neda; Jonjić, Stipan; Rabatić, Sabina;
Differences in NK cell subsets and expression of activating and inhibiting receptors in infants - 1.1.2010.
29.
Slavuljica, Irena; Busche, Andreas; Babić, Marina; Mitrović, Maja; Gašparović, Iva; Cekinović, Đurđica; Markova Car, Elitza; Pernjak Pugel, Ester; Ciković, Ana; Juranić Lisnić, Vanda;
Immunobiology of recombinant CMV Strain expressing ligand for NKG2D receptor-a dramatic attenuation in vivo does not prevent an efficient and long-lasting protective immune response - 1.1.2010.
30.
Zafirova, Biljana; Gulin, Maja; Jonjić, Stipan; Polić, Bojan;
Comparable NK-cell phenotype of Klrk1D/D to the Klrk1-/-mice - 1.1.2010.
31.
Babić Čač, Marina; Zafirova, Biljana; Mitrović, Maja; Pyzik, Michal; Krmpotić, Astrid; Vidal, Silvia M; Jonjić, Stipan;
Mouse cytomegalovirus compromises ‘missing-self’mediated activation of natural killer cells - 1.1.2010.
32.
Mitrović, Maja; Arapović, Jurica; Simić, Hrvoje; Boneta, Jelena; Tomac, Jelena; Krmpotic, Astrid; Jonjić, Stipan;
THE ROLE OF CYTOLYTIC MECHANISMS IN CONTROL OF MOUSE CYTOMEGALOVIRUS INFECTION - 1.1.2010.
33.
Lisnić, Vanda Juranić; Babić, Marina; Tršan, Tihana; Henkel, Andrea; Jonjić, Stipan; Trgovcich, Joanne;
A transcriptomic approach to viral disease research-generation of MCMV cDNA library - 1.1.2009.
34.
Arapović, Jurica; Mitrović, Maja; Šimić, Hrvoje; Krmpotić, Astrid; Jonjić, Stipan;
The importance of cytolytic mechanisms in NK-cell response to mouse cytomegalovirus infection - 1.1.2009.
35.
Zafirova, Biljana; Mandarić, Sanja; Krmpotić, Astrid; Jonsson, Helena; Yokoyama, M Wayne; Jonjić, Stipan; Polić, Bojan;
NKG2D as a major regulator of the development, homeostasis and effector functions of NK cells? - 1.1.2009.
36.
Pernjak Pugel, Ester; Cekinović, Đurđica; Bantug, Glenn; Koontz, Thad; Tomac, Jelena; Britt, William; Jonjić, Stipan;
MCMV infection in newborn mouse brain - 1.1.2009.
37.
Cekinović, Đurđica; Golemac, Mio; Pernjak Pugel, Ester; Tomac, Jelena; Čičin-Šain, Luka; Slavuljica, Irena; Bradford, Russel; Winkler, Thomas H; Misch, Sonja; Mach, Michael;
Passive immunization prevents MCMV-induced pathology in the CNS of newborn mice - 1.1.2008.
38.
Slavuljica, Irena; Markova-Car, Elitza Petkova; Gašparović, Iva; Arapović, Jurica; Cekinović, Đurđica; Krmpotić, Astrid; Jonjić, Stipan;
The Role of NKG2D Immunoevasion Genes During Cronic MCMV Infection - 1.1.2008.
39.
Arapović, Jurica; Lenac, Tihana; Antulov, Ronald; Polić, Bojan; Carayannopoulos, LN; Krmpotić, Astrid; Jonjić, Stipan;
Differential susceptibility of RAE-1 isoforms to murine cytomegalovirus - 1.1.2008.
40.
Krmpotić, Astrid; Babić, Marina; Jonjić, Stipan;
MCMV m04 functions as an NK cell response inhibitor - 1.1.2008.
41.
Gašparović, Iva; Busche, Andreas; Cekinović, Đurđica; Babić, Marina; Slavuljica, Irena; Krmpotić, Astrid; Messerle, Martin; Jonjić, Stipan;
Immunosurveilance of recombinant MCMV expressing NKG2D ligand RAE-1gamma - 1.1.2008.
42.
Cekinović, Đurđica; Bantug, GRB; Tomac, Jelena; Pernjak Pugel, Ester; Britt, W; Jonjić, Stipan;
CD8+ T Lymphocyte Mediated Immune Response in MCMV-Infected Newborn Brain - 1.1.2007.
43.
Arapović, Jurica; Lenac, Tihana; Antulov, Ronald; Krmpotić, Astrid; Hasan, Milena; Polić, Bojan; Jonjić, Stipan;
Differential regulation of RAE-1 isoforms by MCMV - 1.1.2007.
44.
Koontz, Thad; Cekinović, Đurđica; Bantug, Glenn; Jonjić, Stipan; Britt, William;
Murine cytomegalovirus infection induces a complex innate immune response and impairs expression of hoxa5 in the developing hindbrain - 1.1.2007.
45.
Cekinović, Đurđica; Bantug, Glenn; Tomac, Jelena; Pugel, Ester; Britt, William; Jonjić, Stipan;
MCMV-induced encephalitis in newborn mice; MC Summer School; NK Defence and Therapy - 1.1.2007.
46.
Mans, Janet; Natarajan, Kannan; Babić, Marina; Messerle, Martin; Šimić, Hrvoje; Krmpotić, Astrid; Jonjić, Stipan; Margulies, David;
Cellular, structural and physiological characterization of MCMV m153 - 1.1.2007.
47.
Cekinović, Đurđica; Koontz, T; Bantug, GB; Tomac, Jelena; Pernjak Pugel, Ester; Britt, W; Jonjić, Stipan;
Innate Immune Response And Developmental Abnormalities In Murine Cytomegalovirus Infected Newborn Brain - 1.1.2007.
48.
Tomac, Jelena; Cekinović, Đurđica; Arapović, Jurica; Zafirova, Biljana; Panić, Linda; Bralić, Marina; Pernjak Pugel, Ester; Jonjić, Stipan;
Pregnancy modulates the course of MCMV infection in balb/c mice - 1.1.2007.
49.
Zafirova, Biljana; Antulov, Ronald; Mandarić, Sanja; Krmpotić, Astrid; Jonjić, Stipan; Polić, Bojan;
The development and analysis of NKG2D ko mouse - 1.1.2007.
50.
Arapović, Jurica; Lenac, Tihana; Babić, Marina; Antulov, Ronald; Krmpotić, Astrid; Polić, Bojan; Jonjić, Stipan;
Resistance of RAE-1d to down-modulation by MCMV - 1.1.2007.
51.
Bantug, Glenn; Cekinović, Đurđica; Bradford, Russell; Koontz, Thad; Jonjić, Stipan; Britt, William;
CD8+ T-cells mediate MCMV clearance from the newborn CNS - 1.1.2007.
52.
Arapović, Jurica; Lenac, Tihana; Antulov, Ronald; Krmpotić, Astrid; Hasan, Milena; Polić, Bojan; Jonjić, Stipan;
Amino acid sequence motif plwy determines the susceptibility of RAE-1 to down-modulation by m152/gp40 - 1.1.2007.
53.
Šimić, Hrvoje; Baiker, Armin; Babić, Marina; Pothineni, Raveendra; Miklić, Karmela; Baždarić, Danijela; Endesfelder, Manuel; Malić, Suzana; Polić, Bojan; Jonjić, Stipan;
High-throughput monoclonal antibody production against the varicella zoster virus (VZV) proteome - 1.1.2007.
54.
Lenac, Tihana; Budt, Matthias; Arapović, Jurica; Hasan, Milena; Zimmermann, Albert; Šimić, Hrvoje; Krmpotić, Astrid; Messerle, Martin; Ruzsics, Zsolt; Koszinowski, Ulrich H;
The herpesviral Fc eceptor fcr-1 as a potent Down-regulator of the NKG2D ligand - 1.1.2006.
55.
Cekinović, Đurđica; Bantug, GRB; Bralić, Marina; Tomac, Jelena; Pernjak Pugel, Ester; Britt, William; Jonjić, Stipan;
MCMV-induced encephalitis in newborn mice - 1.1.2006.
56.
Girard-Adam, Sonia; Caraux, Anouk; Fodil-Cornu, Nassima; Loredo-Osti, J Concepcion; Lesjean-Pottier, Sarah; Jaubert, Jean; Bubić, Ivan; Jonjić, Stipan; Guenet, Jean-Louis; Vidal, Silvia;
Cmv4, a New Locus Linked to the NK Cell Gene Complex, Controls Innate Resistance to Cytomegalovirus in Wild-Derived Mice - 1.1.2006.
57.
Krmpotić, Astrid; Lenac, Tihana; Hasan, Milena; Arapović, Jurica; Jonjić, Stipan;
Modulation of NK cell response by mouse cytomegalovirus” - 1.1.2006.
58.
Cekinović, Đurđica; Bantug, GRB; Bralić, Marina; Tomac, Jelena; Pernjak Pugel, Ester; Britt, William; Jonjić, Stipan;
MCMV-induced encephalitis in newborn mice: potential role of viral immunoevasion proteins - 1.1.2006.
59.
Čičin-Šain, Luka; Ruzsics, Zsolt; Podlech, Jürgen; Menard, Carine; Bubić, Ivan; Jonjić, Stipan; Reddehase, Matthias; Koszinowski, Ulrich;
The inhibition of death-receptor apoptosis inhibits the antiviral activity of cytokines and allows in vivo replication of the murine cytomegalovirus - 1.1.2006.
60.
Krmpotić, Astrid; Lenac, Tihana; Hasan, Milena; Arapović, Jurica; Jonjić, Stipan;
The role of viral immunoevasins in the pathogenesis of cytomegalovirus infection - 1.1.2006.
61.
Butorac, Višnja; Krmpotić, Astrid; Jonjić, Stipan;
MURINE CYTOMEGALOVIRUS m04/gp34 IS NK CELL DECOY - 1.1.2005.
62.
Muhvić-Urek, Miranda; Bralić, Marina; Ćurić, Stipica; Jonjić, Stipan; Pernjak Pugel, Ester; Tomac, Jelena;
Apoptosis and proliferation in X-irradiated submandibular gland - 1.1.2005.
63.
Arapović, Jurica; Antulov, Ronald; Hasan, Milena; Polić, Bojan; Krmpotić, Astrid; Jonjić, Stipan;
NKG2D LIGAND RAE-1delta ESCAPES MCMV DOWN-MODULATION - 1.1.2005.
64.
Lenac, Tihana; Krmpotić, Astrid; Hasan, Milena; Bubić, Ivan; Halenius, Anne; Ruzsics, Zsolt; Arapović, Jurica; Hengel, Hartmut; Messerle, Martin; Koszinowski, Ulrich;
Regulation of the expression of NKG2D ligands MULT-1 and H60 by MCMV - 1.1.2005.
65.
Hasan, Milena; Krmpotić, Astrid; Lenac, Tihana; Bubić, Ivan; Messerle, Martin; Ruszics, Zsolt; Koszinowski, Ulrich H; Jonjić, Stipan;
Deletion of MCMV m157 gene reveals the function of NKG2D silencing viral genes also in CMV1 positive mice - 1.1.2004.
66.
Jonjić, Stipan;
MOLECULAR AND FUNCTIONAL CHARACTERISATION OF MOUSE CYTOMEGALOVIRUS GENES INVOLVED IN REGULATION OF NK CELL RESPONSE - 1.1.2004.
67.
Bralić, Marina; Bantug, Glenn; Golemac, Mijo; Koontz, Thadeus; Pernjak-Pugel, Ester; Tomac, Jelena; Jonjić, Stipan; Britt, William;
Delayed cerebellar development and altered chemokine expression in the CNS as a result of peripheral murine cytomegalovirus infection of neonatal BALB/c mice - 1.1.2004.
68.
Zimmermann, Albert; Wilborn, Manuel; Wagner, Marcus; Ziade, Toufic; Bubic, Ivan; Trilling, Mirko; Jonjić, Stipan; Koszinowski, Ulrich; Hengel, Hartmut;
A viral protein reveals a biological role for STAT2 in IFN-gamma receptor signaling - 1.1.2003.
69.
Hengel, Hartmut; Zimmermann, Albert; Wilborn, Manuel; Wagner, Marcus; Ziade, Toufic; Bubic, Ivan; Triling, Mirko; Jonjić, Stipan; Koszinowski, Ulrich;
A viral protein reveals a biological role for stat2 in IFNg receptor signaling - 1.1.2003.
70.
Hasan, Milena; Bubić, Ivan; Krmpotić, Astrid; Yokoyama, Wayne; Jonjić, Stipan;
The role of NKG2D co-stimulation in MCMV control by CD8+ T lymphocytes - 1.1.2003.
71.
Bubić, Ivan; Wagner, Markus; Krmpotić, Astrid; Koszinowski, Ulrich; Jonjić, Stipan;
The significance of MCMV m157 gene product in NK cell-medaited control of MCMV infection in vivo - 1.1.2003.
72.
Bubić, Ivan; Wagner, Markus; Krmpotić, Astrid; Koszinowski, Ulrich; Jonjić, Stipan;
The role of MCMV m157 gene product in NK cell-mediated control of MCMV infection in vivo - 1.1.2003.
73.
Čičin-Šain, Luka; Brune, Wolfram; Bubić, Ivan; Jonjić, Stipan; Koszinowski, Ulrich;
Cytomegalovirus Infection in Mice Caused by Bacteria Carring a Cloned MCMV Genome - 1.1.2003.
74.
Bralić, Marina; Pernjak Pugel, Ester; Golemac, Mijo; Tomac, Jelena; Britt, J William; Jonjić, Stipan;
Cerebellar abnormalities induced by citomegaloviral infection - 1.1.2002.
75.
Bralić, Marina; Pernjak Pugel, Ester; Golemac, Mijo; Tomac, Jelena; Britt, J William; Jonjić, Stipan;
Developmental brain disorders during cytomegaloviral infection - 1.1.2002.
76.
Hasan, Milena; Krmpotić, Astrid; Čičin-Šain, Luka; Bralić, Marina; Polić, Bojan; Jonjić, Stipan;
Development of Ig secreting cells in mMT/mMT BALB/c mice - 1.1.1999.
77.
Markotić, Anita; Marušić, Ana; Jonjić, Stipan; Mesarić, Marko; Muething, Johannes;
Ganglioside expression in tissues of mice deficient in beta2-microglobulin - 1.1.1999.
78.
Krmpotić, Astrid; Messerle, Martin; Crnković-Mertens, Irena; Bubić, Ivan; Hengel, Hartmut; Jonjić, Stipan; Koszinowski, Ulrich;
The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against both the adaptive and innate immune response - 1.1.1999.
79.
Štimac, Davor; Trgovcich, Joanne; Polić, Bojan; Pernjak-Pugel, Ester; Tomac, Jelena; Jonjić, Stipan;
Murine cytomegalovirus-induced hepatitis is linked to suppression of immune responses - 1.1.1997.
80.
Trgovcich, Joanne; Štimac, Davor; Polić, Bojan; Zorica, Irena; Crnković, Irena; Pavić, Ivica; Koszinowski, Ulrich; Jonjić, Stipan;
Perturbation of liver function in MCMV-induced hepatitis - 1.1.1997.
81.
Trgovcich, Joanne; Crnković, Irena; Krmpotić, Astrid; Zorica, Irena; Jonjić, Stipan; Koszinowski, Ulrich;
MCMV pathogenesis in neonatal mice - 1.1.1997.
82.
Jonjić, Stipan; Polić, Bojan; Zorica, Irena; Krmpotić, Astrid; Pavić, Ivica; Lučin, Pero; Koszinowski, Ulrich;
Conversion of latent to recurrent MCMV infection is primarily controlled by CD8+ T lymphocytes and NK cells - 1.1.1997.
83.
Radošević-Stašić, Biserka; Jonjić, Stipan; Ćuk, Mira; Šegon, Marija; Rukavina, Daniel;
Inducible expression of class II MHC antigens in the regenerating liver of rats - 1.1.1987.
84.
Dorić, Miljenko; Jonjić, Stipan; Rukavina, Daniel;
Immunological activity of lymphoid organs in pregnant rats - 1.1.1982.

Znanstveni projekti

1. 1.10.2017. - 30.9.2022.
Jačanje kapaciteta CerVirVac-a za istraživanja u virusnoj imunologiji i vakcinologiji; koordinator; Europski fond za regionalni razvoj (EFRR); HRK 37.716.072,15 ( cca EUR 5.000.000,00);
2. 1.5.2017. - 30.5.2022.
Inflammation and hearing loss following congenital CMV infection (resubmission); partner, uz University of Alabama at Birmingham, SAD; National Institutes of Health (NIH) R01; USD 3.659.495, MEDRI: USD 229.500;
3. 1.1.2016. -
The integrated anti-HCMV/anti-GBM vaccine; partner; HAMAG-BICRO Proof of Concept Programme (PoC) 6; HRK 390.000 / HRK 350.000;
4. 1.1.2015. - 1.1.2019.
A training network for the rational design of the next generation of well-defined glycoconjugate vaccines (GLYCOVAX); partner ( coordinator: NOVARTIS vaccines and diagnostics (11 partners, including Faculty of Medicine Rijeka, Stipan Jonjic); HORIZON 2020, Marie Sklodowska-Curie Innovative Training Networks; 3.560.797,00 EUR/ 247.761,00 EUR;
5. 1.1.2014. - 1.1.2018.
Znanstveni centar izvrsnosti za virusnu imunologiju i cjepiva (CERVirVac); koordinator; Ministarstvo znanosti, obrazovanja i sporta; 2.000,000,00;
6. 1.1.2013. - 1.1.2018.
Strengthening adaptive immunity via innate immunity: enhancing the CD8 T cellresponse by using the NKG2D ligand expressed in a herpesvirus vector (StAdvInn); voditelj; EU FP7 ERC; EUR1.754.897 ;
7. 1.1.2013. - 1.1.2016.
Platform for trans-Academic Cooperation in Innovation (PACINNO); partner; IPA Adriatic CBC Strategic project proposals; EUR 636.500;
8. 1.1.2013. - 1.1.2015.
Becoming entrepreneurial: knowledge transfer from the University of Rijek Faculty of Medicine to the biotechnology business sector; partner; EU Instrument for Preaccession Assistance – IPA; EUR 440.000;
9. 1.1.2013. - 1.1.2015.
Methods for high-throughput glycoproteomic analysis (HTP-GlycoMet); partner; FP7 program Marie Curie Actions - Industry-Academia Partnerships and Pathways; EUR1.818.077,90;
10. 1.1.2012. - 1.1.2013.
Novi snažni CMV-promotor za proizvodnju proteina i nekodirajućih molekula RNA; voditelj; BICRO; HRK 390.000/350.000;
11. 1.1.2011. - 1.1.2016.
Congenital CMV and CNS infection mechanisms of protective immunity; su-istraživač; NationalInstitutes of Health (NIH) SAD ; USD 500.000;
12. 1.1.2011. - 1.1.2016.
Viral Strategies of Immune Evasion (VISTRIE); partner; Helmholtz Association; EUR 4.500.000;
13. 1.1.2010. - 1.1.2015.
MCMV Infection of the Developing CNS: Neuroinvasion and immune Control; su-voditelj; National Institutes of Health (NIH) USA; USD 350.000;
14. 1.1.2009. - 1.1.2013.
Viral evasion of NK cells ; voditelj; National Institutes of Health (NIH) SAD; USD 270.249;
15. 1.1.2007. - 1.1.2011.
Molekularni mehanizmi citomegalovirusnog izmicanja imunološkom nadzoru; voditelj ; MZOŠ; EUR 102.740;

Mentorstvo doktorandima

1. 1.1.2013. -
Ilija Brizić; Doktorat obrana teme: Uloga citomegalovirusnog proteina MCK-2 u tropizmu virusa i imunološkom odgovoru; Biomedicina; 13.4.2015.;
2. 1.1.2013. -
Lea Hiršl; Doktorat ; Biomedicina; ;
3. 1.1.2009. - 1.1.2015.
Tihana Tršan; Doktorat Utjecaj ekspresije liganda za receptor NKG2D na potencijal citomegalovirusa kao vakcinskoga vektora ; Biotehnologija i bioprocesno inženjerstvo, Prehrambeno-biotehnološki fakultet Zagreb; 20.2.2015.;
4. -
Ivica Pavić; Doktorat Značaj citokina u nadzoru citomegalovirusne infekcije.; Msc., PhD; 1992., 1995.;
5. -
Marina Bralić ; Magisterij ; Msc.; 2004.;
6. -
Milena Hasan ; Doktorat Uloga imunosubverzivnih gena mišjeg citomegalovirusa u izbjegavanju imunosnog nadzora posredovanog NK-limfocitima.; Msc., PhD; 2000. , 2004.;
7. -
Davor Štimac; Doktorat Mehanizmi imunološkog nadzora citomegalovirusne infekcije jetre; PhD; 1997.;
8. -
Jurica Arapovic; Doktorat Molekularna osnova različite osjetljivosti proteina RAE-1 na regulaciju citomegalovirusom; PhD.; 2009.;
9. -
Bojan Polić; Doktorat Mehanizmi imunološkog nadzora latentne herpesvirusne infekcije; Msc., PhD; 1993., 1996.;
10. -
Maja Arapovic ; Doktorat Uloga NK-stanica u modulaciji specifičnog imunološkog odgovora na virus; PhD.; 2013.;
11. -
Marina Babic Cac ; Doktorat Virusna regulacija aktivnosti NK-limfocita:uloga inhibicijskih Ly49 receptora.; PhD.; 2011.;
12. -
Irena Milotic ; Doktorat Karakterizacija humanog citomegalovirusa s delecijom homologa receptora vezanih za G-protein.; PhD; 2005.;
13. -
Pero Lucin ; Doktorat Regulacijski učinak T limfocita i citokina na pojavu autoantitijela tijekom infekcije citomegalovirusom.; M.sc., PhD; 1989, 1991;
14. -
Vanda Juranić Lisnić; Doktorat Analiza transkriptoma mišjeg citomegalovirusa; PhD.; 2013.;
15. -
Astrid Krmpotić; Doktorat Uloga herpesvirusnih gena u izbjegavanju imunološkog nadzora posredovanog limfocitima T i NK-stanicama in vivo; Msc., PhD; 1998., 2001.;
16. -
Irena Crnković; Doktorat Uloga citomegalovirusnih gena u izbjegavanju imunološkog nadzora pomoću rekombinantnih virusa.; Msc., PhD; 1994., 1997.;
17. -
Ivan Bubic ; Doktorat Imunobiologija citomegalovirusnih proteina kao liganada za aktivacijske receptore NK-stanicama; PhD.; 2005.;
18. -
Dubravka Matanic ; Doktorat In vitro otpuštanje citokina iz plućnih makrofaga izoliranih bronhoalveolarnom lavažom u bolesnika s malignim tumorom pluća.; PhD.; 1999.;
19. -
Irena Slavuljica ; Doktorat Uloga NKG2D receptora u imunološkom nadzoru citomegalovirusne infekcije; PhD.; 2012.;
20. -
Luka Cicin-Sain ; Doktorat Komplementacija citomegalovirusnih varijanti in vivo; Msc., PhD; 2004. , 2006.;
21. -
Tihana Lenac Rovis; Doktorat Imunosubverzivni učinak mišjeg citomegalovirusa na NK-stanice; PhD.; 2007.;
22. -
Faruk Skenderi ; Doktorat Izolacija i karakterizacija monoklonskih antitijela specifičnih na m74 genski produkt mišjeg citomegalovirusa; Msc. Medicinski fakultet Univerzitet u Sarajevu; 2011.;
23. -
Djurdjica Cekinovic; Doktorat Imunološki nadzor prirođene citomegalovirusne infekcije mozga u novookoćenih miševa - zaštitna uloga stanične imunosti i protuvirusnih protutijela; PhD.; 2011.;

Znanstveni skupovi

1. 28.8.2016. - 5.9.2007.
Marie Curie Summer School "NK Defence and Therapy", i EPO Course Božava, Dugi otok organizator
2. 30.7.2016. - 5.8.2005.
30th International Herpesvirus Workshop IHW Turku, Finska član znanstvenog odbora
3. 25.9.2015. -
Vaccination and immunotherapy in defense against infectious diseases and tumors symposium, suorganizatori:Hrvatska akademija znanosti i umjetnosti i Znanstveni centar izvrsnosti za virusnu imunologiju i cjepiva Rijeka su-organizator
4. 10.4.2015. -
Završna konferencija projekta ''Prema poduzetničkom sveučilištu: Prijenos znanja s Medicinskog fakulteta Sveučilišta u Rijeci u biotehnološki poslovni sektor – EntrepMEDRI'' Medicinski fakultet Sveučilišta u Rijeci organizator
5. 21.3.2014. -
IV IPA trening radionica ''Pre-clinical testing opportunities'' u sklopu projekta ''Prema poduzetničkom sveučilištu: Prijenos znanja s Medicinskog fakulteta Sveučilišta u Rijeci u biotehnološki poslovni sektor'', financirana sredstvima programa IPA SIIF Medicinski fakultet Sveučilišta u Rijeci organizator
6. 6.12.2013. -
III IPA trening radionica ''Strategije partnerstva u razvoju dijagnostičkih metoda'' u skopu projekta ''Prema poduzetničkom sveučilištu: prijenos znanja s Medicinskog fakulteta u Rijeci u biotehnološki poslovni sektor'', financirana sredstvima programa IPA SIIF Medicinski fakultet Sveučilišta u Rijeci, organizator
7. 15.10.2013. -
II IPA trening radionica ''Učinkovita translacija istraživanja i razvoja cjepiva'' u skopu projekta ''Prema poduzetničkom sveučilištu: prijenos znanja s Medicinskog fakulteta u Rijeci u biotehnološki poslovni sektor'', financirana sredstvima programa IPA SIIF Medicinski fakultet Sveučilišta u Rijeci organizator
8. 15.7.2013. -
IPA trening radionica o strategijama komercijalizacije ''MEDRI meets industry'', - Prema poduzetničkom sveučilištu: prijenos znanja s Medicinskog fakulteta u Rijeci u biotehnološki poslovni sektor, financirana sredstvima programa IPA SIIF Medicinski fakultet Sveučilišta u Rijeci organizator
9. 23.3.2007. -
Croatian – Israeli Kick-off Meeting on Viral Immunology and Pathogenesis Rijeka organizator
10. 1.1.2005. -
Godišnji simpozij Hrvatskog imunološkog društva Božava, Dugi otok predsjednik
11. 1.1.2004. -
Godišnji simpozij Hrvatskog imunološkog društva Opatija predsjednik
12. 1.1.2003. -
Godišnji simpozij Hrvatskog imunološkog društva Brijuni predsjednik
13. 1.1.2002. -
Godišnji simpozij Hrvatskog imunološkog društva Trakošćan predsjednik
14. - 27.5.2015.
3rd Belgrade EFIS symposium on immunoregulation, immunity, infection, autoimmunity and aging ( organizatori: Miodrag Lukić, Stipan Jonjić, Janko Nikolich-Zugich) Beograd, Srbija su-organizator
15. - 24.6.2014.
II sastanak Upravnog i Savjetodavnog odbora projekta PACINNO (Platform for trans-Academic Cooperation in Innovation)-IPA Medicinski fakultet Sveučilišta u Rijeci organizator
16. - 22.5.2012.
Workshop on Congenital Infections, TransMedRi, Department of Histology & Embryology, Faculty of Medicine, University of Rijeka Rijeka organizator
17. - 16.3.2012.
Small Animal Imaging Workshop, TransMedRi, Department of Histology & Embryology, Faculty of Medicine, University of Rijeka Rijeka organizator
18. - 14.2.2012.
Antibody engineering: from murine hybridoma to therapeutics - 3rd CAPRI2010 Advanced Laboratory Workshop Rijeka organizator
19. - 27.10.2011.
Advanced production techniques for complex protein biologics - 2st CAPRI2010 AdvancedLaboratory Workshop Rijeka organizator
20. - 8.5.2011.
Fc protein expression of type I and type II proteins - 1st CAPRI2010 Advanced Laboratory Workshop" Rijeka organizator
21. - 15.9.2010.
12th Meeting of the Society for Natural Immunity Cavtat organizator
22. - 17.6.2009.
Advanced Laboratory Training Course : Viral Subversion of Immune Response, Howard Hughes Medical Institute Rijeka organizator
23. - 29.9.2004.
BMBF Summer School "Proteomics Basics" (u suradnji s Henning Urlaub, Max-Planck-Institute for Biophysical Chemistry) Opatija suorganizator
24. - 6.7.2001.
VIII International Congress of Reproductive Immunology Opatija član organizacijskog odbora
25. - 19.9.1998.
Fourth International Meeting "Mechanisms in Local Immunity" Opatija član organizacijskog odbora

Patenti

1. 2017. Mandelboim Ofer, Jonjic Stipan, Berhani Orit, Glasner Ariella
ANTI-NKp46 ANTIBODIES AND THERAPEUTIC USE OF SAME,
anti-NKp46
2. 2017. Jonjic, Stipan, Simic, Hrvoje, Lisnic Berislav
INTEGRATED HUMAN CYTOMEGALOVIRUS / GLIOBLASTOMA VACCINE
Glioblastoma vaccine
3. 2016. Mandelboim Ofer, Jonjic Stipan, Berhani Orit, Glasner Ariella:
DEVELOPMENT OF AN ANTI-NKp46 mAb FOR THE EVALUATION OF NKp46 ACTIVITIES IRRESPECTIVE OF THE IDENTITY OF ITS LIGANDS.
anti-NKp46 mAb
4. 2016. Mandelboim Ofer, Kaynan Noa, Pinchas Tsukerman, Jonjic Stipan
ANTIBODIES SPECIFIC TO HUMAN T-CELL IMMUNOGLOBULIN AND ITIM DOMAIN (TIGIT)

5. 2016. Mandelboim Ofer, Pinchas Tsukerman, Kaynan Noa, Jonjic Stipan
ANTI-POLIOVIRUS RECEPTOR ANTIBODIES AND THE USE OF SAME FOR THE TREATMENT OF TUMORS.

6. 2015. Mandelboim Ofer, Jonjic Stipan, Kaynan Noa
INHIBITION OF T-CELL IMMUNOGLOBULIN AND ITIM DOMAIN (TIGIT) PROTECTS TUMORS FROM IMMUNE CELL ATTACK
TIGIT
7. 2015. Mandelboim Ofer, Kaynan Noa, Pinchas Tsukerman, Jonjic Stipan
ANTIBODIES SPECIFIC TO T-CELL IMMUNOGLOBULIN AND ITIM DOMAIN (TIGIT).

8. 2015. Mandelboim Ofer, Kaynan Noa, Jonjic Stipan:
ANTIBODIES SPECIFIC TO T-CELL IMMUNOGLOBULIN AND ITIM DOMAIN (TIGIT).

9. 2012. Stipan Jonjić
VACCINES COMPRISING BETA-HERPESVIRUS

Uredništva časopisa

1. - PlosPathogens

2. - Microbes and Infections

3. - Herpesviridae

4. - Frontiers in Microbial Immunity

5. - European Journal of Immunology (EJI)

6. - Current Immunology Reviews -Editorial Advisory Board Member

7. - Acta Medica Academica

Recenzije

1. Plos One
2. PloS Pathogens
3. Periodicum Biologorum
4. French Research Agency (FRA) - Microbiology, Immunology and Infection panel
5. Nacionalna zaklada za znanost, visoko školstvo i tehnologijski razvoj Republike Hrvatske
6. Ministarstvo znanosti, obrazovanja i športa
7. NIAID Special Emphasis Panel Review
8. The Journal of Infectuous Diseases
9. Virology
10. Methods in Virology
11. Journal of Leukocyte Biology
12. Journal of General Virology
13. Immunity
14. International Immunopharmacology
15. International Immunology
16. Medical Microbiology and Immunology
17. Journal of Virology
18. Journal of Cellular and Molecular Medicine
19. Journal of Experimental Medicine
20. Nature Immunology
21. Croatian Medical Journal
22. Cell Host & Microbe
23. Infection and Immunity
24. Expert Review of Vaccines
25. Blood
26. Archives of Virology
27. Antiviral Research

Administrativna djelatnost

Rukovođenje na sveučilištu

1. 1.1.2013. - - pomoćnik rektora - predsjednik
Savjet za znanost Sveučilišta u Rijeci
2. 1.1.2006. - - Voditelj Centra za proteomiku
Medicinski fakultet u Rijeci
3. 1.1.1999. - 1.1.2003. - dekan
Medicinski fakultet Rijeka
4. 1.1.1996. - - Predstojnik Zavoda/Katedre za histologiju i embriologiju
Medicinski fakultet Rijeka

Povjerenstva na sveučilištu

1. - - član povjerenstva
Povjerenstvo za izbor nastavnika, znanstvenika i suradnika